OA17665A - Biocide compositions - Google Patents
Biocide compositions Download PDFInfo
- Publication number
- OA17665A OA17665A OA1201600005 OA17665A OA 17665 A OA17665 A OA 17665A OA 1201600005 OA1201600005 OA 1201600005 OA 17665 A OA17665 A OA 17665A
- Authority
- OA
- OAPI
- Prior art keywords
- alkyl
- hydrogen
- acid
- independently
- chch
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 225
- 230000003115 biocidal Effects 0.000 title claims abstract description 47
- 239000003139 biocide Substances 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000010779 crude oil Substances 0.000 claims abstract description 7
- 238000003860 storage Methods 0.000 claims abstract description 7
- 238000004642 transportation engineering Methods 0.000 claims abstract description 6
- 239000001257 hydrogen Substances 0.000 claims description 180
- 229910052739 hydrogen Inorganic materials 0.000 claims description 180
- -1 imidazoline compound Chemical class 0.000 claims description 128
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims description 106
- 125000000217 alkyl group Chemical group 0.000 claims description 76
- 125000001424 substituent group Chemical group 0.000 claims description 59
- 150000001412 amines Chemical class 0.000 claims description 44
- 239000002253 acid Substances 0.000 claims description 41
- 125000003342 alkenyl group Chemical group 0.000 claims description 39
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 35
- 239000007789 gas Substances 0.000 claims description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 31
- 239000000194 fatty acid Substances 0.000 claims description 31
- 150000004665 fatty acids Chemical class 0.000 claims description 29
- 125000000623 heterocyclic group Chemical group 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000001072 heteroaryl group Chemical group 0.000 claims description 21
- 125000000304 alkynyl group Chemical group 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 20
- 125000005466 alkylenyl group Chemical group 0.000 claims description 16
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 16
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 125000006528 (C2-C6) alkyl group Chemical group 0.000 claims description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 9
- 229910018828 PO3H2 Inorganic materials 0.000 claims description 9
- 235000019270 ammonium chloride Nutrition 0.000 claims description 9
- YIEDHPBKGZGLIK-UHFFFAOYSA-L tetrakis(hydroxymethyl)phosphanium;sulfate Chemical compound [O-]S([O-])(=O)=O.OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO YIEDHPBKGZGLIK-UHFFFAOYSA-L 0.000 claims description 8
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 7
- 244000052616 bacterial pathogens Species 0.000 claims description 6
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 6
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- HWZPDEDBPRSNKC-UHFFFAOYSA-N 1-amino-2-(dimethylamino)-3-phenylpropan-2-ol Chemical compound CN(C)C(O)(CN)CC1=CC=CC=C1 HWZPDEDBPRSNKC-UHFFFAOYSA-N 0.000 claims description 3
- FOXPGXQCPGOJEC-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]-3-phenylpropan-1-ol Chemical compound OCCN(CCO)C(CO)CC1=CC=CC=C1 FOXPGXQCPGOJEC-UHFFFAOYSA-N 0.000 claims description 3
- SXPWTBGAZSPLHA-UHFFFAOYSA-M Cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 claims description 3
- WOWHHFRSBJGXCM-UHFFFAOYSA-M Cetrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 3
- YMBCJWGVCUEGHA-UHFFFAOYSA-M Tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 claims description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M Tetramethylammonium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 3
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 claims description 3
- 229960000228 cetalkonium chloride Drugs 0.000 claims description 3
- ZYNUSOWWGMTZHH-UHFFFAOYSA-L oxalate;tetrakis(hydroxymethyl)phosphanium Chemical compound [O-]C(=O)C([O-])=O.OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO ZYNUSOWWGMTZHH-UHFFFAOYSA-L 0.000 claims description 3
- ODTSDWCGLRVBHJ-UHFFFAOYSA-M tetrahexylazanium;chloride Chemical compound [Cl-].CCCCCC[N+](CCCCCC)(CCCCCC)CCCCCC ODTSDWCGLRVBHJ-UHFFFAOYSA-M 0.000 claims description 3
- VELJAQNIUXJKSV-UHFFFAOYSA-M tetrakis(hydroxymethyl)phosphanium;acetate Chemical compound CC([O-])=O.OC[P+](CO)(CO)CO VELJAQNIUXJKSV-UHFFFAOYSA-M 0.000 claims description 3
- AKXUUJCMWZFYMV-UHFFFAOYSA-M tetrakis(hydroxymethyl)phosphanium;chloride Chemical compound [Cl-].OC[P+](CO)(CO)CO AKXUUJCMWZFYMV-UHFFFAOYSA-M 0.000 claims description 3
- KSEKSWYSOJKTGU-UHFFFAOYSA-M tetrakis(hydroxymethyl)phosphanium;formate Chemical compound [O-]C=O.OC[P+](CO)(CO)CO KSEKSWYSOJKTGU-UHFFFAOYSA-M 0.000 claims description 3
- ZTBDCHNXDHUMCJ-UHFFFAOYSA-K tetrakis(hydroxymethyl)phosphanium;phosphate Chemical compound [O-]P([O-])([O-])=O.OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO ZTBDCHNXDHUMCJ-UHFFFAOYSA-K 0.000 claims description 3
- SNNIPOQLGBPXPS-UHFFFAOYSA-M tetraoctylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC SNNIPOQLGBPXPS-UHFFFAOYSA-M 0.000 claims description 3
- FBEVECUEMUUFKM-UHFFFAOYSA-M tetrapropylazanium;chloride Chemical compound [Cl-].CCC[N+](CCC)(CCC)CCC FBEVECUEMUUFKM-UHFFFAOYSA-M 0.000 claims description 3
- ICTMDIORIDZWQN-UHFFFAOYSA-M triethyl(phenyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)C1=CC=CC=C1 ICTMDIORIDZWQN-UHFFFAOYSA-M 0.000 claims description 3
- MQAYPFVXSPHGJM-UHFFFAOYSA-M trimethyl(phenyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)C1=CC=CC=C1 MQAYPFVXSPHGJM-UHFFFAOYSA-M 0.000 claims description 3
- XKXHCNPAFAXVRZ-UHFFFAOYSA-N benzylazanium;chloride Chemical compound [Cl-].[NH3+]CC1=CC=CC=C1 XKXHCNPAFAXVRZ-UHFFFAOYSA-N 0.000 claims 1
- 239000003345 natural gas Substances 0.000 abstract description 5
- 238000000926 separation method Methods 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 description 62
- MTNDZQHUAFNZQY-UHFFFAOYSA-N 2-Imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 51
- 239000012530 fluid Substances 0.000 description 39
- 150000001875 compounds Chemical class 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 27
- 102100000129 CHURC1 Human genes 0.000 description 27
- 101710014631 CHURC1 Proteins 0.000 description 27
- 239000003112 inhibitor Substances 0.000 description 23
- 230000002401 inhibitory effect Effects 0.000 description 23
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 20
- 150000002462 imidazolines Chemical class 0.000 description 19
- 238000005260 corrosion Methods 0.000 description 18
- 150000003254 radicals Chemical group 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 238000007792 addition Methods 0.000 description 15
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 239000004215 Carbon black (E152) Substances 0.000 description 13
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 12
- DPUOLQHDNGRHBS-KTKRTIGZSA-N Erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 11
- 125000004432 carbon atoms Chemical group C* 0.000 description 11
- 150000002430 hydrocarbons Chemical class 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 150000004714 phosphonium salts Chemical class 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-Ethylhexanol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 10
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000002195 synergetic Effects 0.000 description 9
- 239000003784 tall oil Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 229960004592 isopropanol Drugs 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N 60-33-3 Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 150000001408 amides Chemical class 0.000 description 7
- 150000003868 ammonium compounds Chemical class 0.000 description 7
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzyl-dodecyl-dimethylazanium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 7
- 239000002270 dispersing agent Substances 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 235000020778 linoleic acid Nutrition 0.000 description 7
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 7
- DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- VKOBVWXKNCXXDE-UHFFFAOYSA-N Arachidic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butanoic acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- FUZZWVXGSFPDMH-UHFFFAOYSA-N Hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- QZZGJDVWLFXDLK-UHFFFAOYSA-N Lignoceric acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 6
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 6
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 6
- FBUKVWPVBMHYJY-UHFFFAOYSA-N Nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- SECPZKHBENQXJG-FPLPWBNLSA-N Palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 6
- CUXYLFPMQMFGPL-BGDVVUGTSA-N Punicic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 6
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 6
- 230000000813 microbial Effects 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- 239000012188 paraffin wax Substances 0.000 description 6
- 229920000098 polyolefin Polymers 0.000 description 6
- 150000004671 saturated fatty acids Chemical class 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000003760 tallow Substances 0.000 description 6
- CUXYLFPMQMFGPL-SUTYWZMXSA-N β-Eleostearic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 6
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-Butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 5
- RPNUMPOLZDHAAY-UHFFFAOYSA-N DETA Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 5
- 239000005642 Oleic acid Substances 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- AVKOENOBFIYBSA-WMPRHZDHSA-N (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O AVKOENOBFIYBSA-WMPRHZDHSA-N 0.000 description 4
- OQOCQFSPEWCSDO-JLNKQSITSA-N (6Z,9Z,12Z,15Z,18Z)-henicosa-6,9,12,15,18-pentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O OQOCQFSPEWCSDO-JLNKQSITSA-N 0.000 description 4
- YHGJECVSSKXFCJ-KUBAVDMBSA-N (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O YHGJECVSSKXFCJ-KUBAVDMBSA-N 0.000 description 4
- DQGMPXYVZZCNDQ-OBWVEWQSSA-N (8E,10E,12E)-octadeca-8,10,12-trienoic acid Chemical compound CCCCC\C=C\C=C\C=C\CCCCCCC(O)=O DQGMPXYVZZCNDQ-OBWVEWQSSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- DQGMPXYVZZCNDQ-KBPWROHVSA-N Calendic acid Chemical compound CCCCC\C=C/C=C/C=C/CCCCCCC(O)=O DQGMPXYVZZCNDQ-KBPWROHVSA-N 0.000 description 4
- OSVXSBDYLRYLIG-UHFFFAOYSA-N Chlorine dioxide Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- TWSWSIQAPQLDBP-DOFZRALJSA-N Docosatetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O TWSWSIQAPQLDBP-DOFZRALJSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 4
- HXQHFNIKBKZGRP-URPRIDOGSA-N Pinolenic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 description 4
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical class OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 4
- JIWBIWFOSCKQMA-LTKCOYKYSA-N Stearidonic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O JIWBIWFOSCKQMA-LTKCOYKYSA-N 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- RWSOTUBLDIXVET-UHFFFAOYSA-N dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000001590 oxidative Effects 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 4
- 239000002351 wastewater Substances 0.000 description 4
- CUXYLFPMQMFGPL-WPOADVJFSA-N α-Eleostearic acid Chemical compound CCCC\C=C\C=C\C=C/CCCCCCCC(O)=O CUXYLFPMQMFGPL-WPOADVJFSA-N 0.000 description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N γ-Linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 4
- XSXIVVZCUAHUJO-HZJYTTRNSA-N (11Z,14Z)-eicosadienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-HZJYTTRNSA-N 0.000 description 3
- VJILEYKNALCDDV-OIISXLGYSA-N (1S,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethylphenanthrene-1-carboxylic acid Chemical compound C1=C(O)C=C2[C@@]3(C)CCC[C@@](C(O)=O)(C)[C@@H]3CCC2=C1 VJILEYKNALCDDV-OIISXLGYSA-N 0.000 description 3
- RZHACVKGHNMWOP-ZWZRQGCWSA-N (2E,4E,6E,8E)-tetracosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O RZHACVKGHNMWOP-ZWZRQGCWSA-N 0.000 description 3
- WSEBKJRVPMLGFV-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-(2-hydroxyethyl)-dimethylazanium;chloride Chemical compound [Cl-].OCC[N+](C)(C)CC(O)CCl WSEBKJRVPMLGFV-UHFFFAOYSA-M 0.000 description 3
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 description 3
- VENRYLMOFDSSDJ-WMPRHZDHSA-N (6Z,9Z,12Z,15Z,18Z)-tetracosapentaenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC(O)=O VENRYLMOFDSSDJ-WMPRHZDHSA-N 0.000 description 3
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 3
- NPTIBOCVSPURCS-JLNKQSITSA-N (9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O NPTIBOCVSPURCS-JLNKQSITSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- 229940114079 Arachidonic Acid Drugs 0.000 description 3
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 3
- 235000021357 Behenic acid Nutrition 0.000 description 3
- QQXWWCIEPUFZQL-JMFSJNRSSA-N Bosseopentaenoic acid Chemical compound CCCCC\C=C/C=C/C=C/C=C\C\C=C/CCCC(O)=O QQXWWCIEPUFZQL-JMFSJNRSSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 3
- 229910000975 Carbon steel Inorganic materials 0.000 description 3
- HVUCKZJUWZBJDP-UHFFFAOYSA-N Ceroplastic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O HVUCKZJUWZBJDP-UHFFFAOYSA-N 0.000 description 3
- XMHIUKTWLZUKEX-UHFFFAOYSA-N Cerotic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 3
- 235000021292 Docosatetraenoic acid Nutrition 0.000 description 3
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 3
- 229960005135 Eicosapentaenoic Acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N Eicosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N Elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 3
- CKDDRHZIAZRDBW-UHFFFAOYSA-N Heneicosylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(O)=O CKDDRHZIAZRDBW-UHFFFAOYSA-N 0.000 description 3
- ONLMUMPTRGEPCH-UHFFFAOYSA-N Hentriacontylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O ONLMUMPTRGEPCH-UHFFFAOYSA-N 0.000 description 3
- VXZBFBRLRNDJCS-UHFFFAOYSA-N Heptacosylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VXZBFBRLRNDJCS-UHFFFAOYSA-N 0.000 description 3
- KEMQGTRYUADPNZ-UHFFFAOYSA-N Heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N Heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- LRKATBAZQAWAGV-UHFFFAOYSA-N Hexatriacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O LRKATBAZQAWAGV-UHFFFAOYSA-N 0.000 description 3
- ICAIHSUWWZJGHD-UHFFFAOYSA-N Lacceroic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O ICAIHSUWWZJGHD-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 235000021353 Lignoceric acid Nutrition 0.000 description 3
- 229920001732 Lignosulfonate Polymers 0.000 description 3
- OYHQOLUKZRVURQ-UHFFFAOYSA-N Linoleic acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 3
- 229960004488 Linolenic Acid Drugs 0.000 description 3
- VHOCUJPBKOZGJD-UHFFFAOYSA-N Melissic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 3
- 235000021360 Myristic acid Nutrition 0.000 description 3
- YWWVWXASSLXJHU-WAYWQWQTSA-N Myristoleic acid Chemical compound CCCC\C=C/CCCCCCCC(O)=O YWWVWXASSLXJHU-WAYWQWQTSA-N 0.000 description 3
- YWWVWXASSLXJHU-AATRIKPKSA-N Myristoleic acid Natural products CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 3
- IHEJEKZAKSNRLY-UHFFFAOYSA-N Nonacosylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O IHEJEKZAKSNRLY-UHFFFAOYSA-N 0.000 description 3
- ISYWECDDZWTKFF-UHFFFAOYSA-N Nonadecylic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 235000021319 Palmitoleic acid Nutrition 0.000 description 3
- 239000005643 Pelargonic acid Substances 0.000 description 3
- MWMPEAHGUXCSMY-UHFFFAOYSA-N Pentacosylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O MWMPEAHGUXCSMY-UHFFFAOYSA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N Pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N Phosphorus pentoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 3
- HQRWEDFDJHDPJC-UHFFFAOYSA-N Psyllic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O HQRWEDFDJHDPJC-UHFFFAOYSA-N 0.000 description 3
- JBYXPOFIGCOSSB-UQGDGPGGSA-N Rumenic acid Chemical compound CCCCCC\C=C/C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-UQGDGPGGSA-N 0.000 description 3
- UTGPYHWDXYRYGT-UHFFFAOYSA-N Tetratriacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTGPYHWDXYRYGT-UHFFFAOYSA-N 0.000 description 3
- XEZVDURJDFGERA-UHFFFAOYSA-N Tricosylic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)=O XEZVDURJDFGERA-UHFFFAOYSA-N 0.000 description 3
- SZHOJFHSIKHZHA-UHFFFAOYSA-N Tridecylic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 3
- ZDPHROOEEOARMN-UHFFFAOYSA-N Undecylic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 3
- UWHZIFQPPBDJPM-BQYQJAHWSA-N Vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 3
- 235000021322 Vaccenic acid Nutrition 0.000 description 3
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004948 alkyl aryl alkyl group Chemical group 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 150000004982 aromatic amines Chemical class 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 229940116226 behenic acid Drugs 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000010962 carbon steel Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 3
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- 229960004363 doconexent Drugs 0.000 description 3
- CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 description 3
- 229950008690 docosanoic acid Drugs 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229940044550 gamma-Linolenic Acid Drugs 0.000 description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 3
- 229960002733 gamolenic acid Drugs 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 3
- 125000005842 heteroatoms Chemical group 0.000 description 3
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 3
- SZQQHKQCCBDXCG-UHFFFAOYSA-N hexadeca-2,4,6-trienoic acid Chemical compound CCCCCCCCCC=CC=CC=CC(O)=O SZQQHKQCCBDXCG-UHFFFAOYSA-N 0.000 description 3
- IQLUYYHUNSSHIY-UHFFFAOYSA-N icosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCC=CC=CC=CC=CC(O)=O IQLUYYHUNSSHIY-UHFFFAOYSA-N 0.000 description 3
- BBWMTEYXFFWPIF-UHFFFAOYSA-N icosa-2,4,6-trienoic acid Chemical compound CCCCCCCCCCCCCC=CC=CC=CC(O)=O BBWMTEYXFFWPIF-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 235000021290 n-3 DPA Nutrition 0.000 description 3
- 235000021288 n-6 DPA Nutrition 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229960002446 octanoic acid Drugs 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229930001613 podocarpic acid Natural products 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- NNNVXFKZMRGJPM-KHPPLWFESA-N sapienic acid Chemical compound CCCCCCCCC\C=C/CCCCC(O)=O NNNVXFKZMRGJPM-KHPPLWFESA-N 0.000 description 3
- 239000002455 scale inhibitor Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- IJTNSXPMYKJZPR-BYFNFPHLSA-N trans-parinaric acid Chemical compound CC\C=C\C=C\C=C\C=C\CCCCCCCC(O)=O IJTNSXPMYKJZPR-BYFNFPHLSA-N 0.000 description 3
- 229940005605 valeric acid Drugs 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- MWKFXSUHUHTGQN-UHFFFAOYSA-N 1-Decanol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- GPUKMTQLSWHBLZ-UHFFFAOYSA-N 1-phenyltridecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCC(S(O)(=O)=O)C1=CC=CC=C1 GPUKMTQLSWHBLZ-UHFFFAOYSA-N 0.000 description 2
- ZZXDRXVIRVJQBT-UHFFFAOYSA-N 2,3-dimethylbenzenesulfonic acid Chemical compound CC1=CC=CC(S(O)(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-N 0.000 description 2
- VLSRKCIBHNJFHA-UHFFFAOYSA-N 2-(trifluoromethyl)prop-2-enoic acid Chemical compound OC(=O)C(=C)C(F)(F)F VLSRKCIBHNJFHA-UHFFFAOYSA-N 0.000 description 2
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 2
- HEBDGRTWECSNNT-UHFFFAOYSA-N 2-methylidenepentanoic acid Chemical compound CCCC(=C)C(O)=O HEBDGRTWECSNNT-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- WJQOZHYUIDYNHM-UHFFFAOYSA-N 2-tert-Butylphenol Chemical compound CC(C)(C)C1=CC=CC=C1O WJQOZHYUIDYNHM-UHFFFAOYSA-N 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-O 4,5-dihydro-1H-imidazol-1-ium Chemical compound C1CN=C[NH2+]1 MTNDZQHUAFNZQY-UHFFFAOYSA-O 0.000 description 2
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 2
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-L CHEBI:8154 Chemical class [O-]P([O-])=O ABLZXFCXXLZCGV-UHFFFAOYSA-L 0.000 description 2
- 239000004155 Chlorine dioxide Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N Decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N Methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N Montanic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- TTZMPOZCBFTTPR-UHFFFAOYSA-N O=P1OCO1 Chemical compound O=P1OCO1 TTZMPOZCBFTTPR-UHFFFAOYSA-N 0.000 description 2
- URXZXNYJPAJJOQ-FPLPWBNLSA-N Paullinic acid Chemical compound CCCCCC\C=C/CCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-FPLPWBNLSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- DQWPFSLDHJDLRL-UHFFFAOYSA-N Triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N acrylaldehyde Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 150000001253 acrylic acids Chemical class 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 230000001476 alcoholic Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000006177 alkyl benzyl group Chemical group 0.000 description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 2
- 125000005120 alkyl cycloalkyl alkyl group Chemical group 0.000 description 2
- 125000005233 alkylalcohol group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 150000003975 aryl alkyl amines Chemical group 0.000 description 2
- IPTLKMXBROVJJF-UHFFFAOYSA-N azanium;methyl sulfate Chemical compound N.COS(O)(=O)=O IPTLKMXBROVJJF-UHFFFAOYSA-N 0.000 description 2
- 239000002551 biofuel Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 235000019398 chlorine dioxide Nutrition 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 238000004939 coking Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 229940093476 ethylene glycol Drugs 0.000 description 2
- 150000002193 fatty amides Chemical class 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000000295 fuel oil Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 150000001469 hydantoins Chemical class 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 150000002443 hydroxylamines Chemical class 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000003951 lactams Chemical class 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 230000000670 limiting Effects 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N n-methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000003068 static Effects 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- FAUOSXUSCVJWAY-UHFFFAOYSA-N tetrakis(hydroxymethyl)phosphanium Chemical class OC[P+](CO)(CO)CO FAUOSXUSCVJWAY-UHFFFAOYSA-N 0.000 description 2
- 150000003918 triazines Chemical class 0.000 description 2
- 230000003442 weekly Effects 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- IJTNSXPMYKJZPR-ZSCYQOFPSA-N α-Parinaric acid Chemical compound CC\C=C/C=C/C=C/C=C\CCCCCCCC(O)=O IJTNSXPMYKJZPR-ZSCYQOFPSA-N 0.000 description 2
- HVGRZDASOHMCSK-HZJYTTRNSA-N (13Z,16Z)-docosadienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-HZJYTTRNSA-N 0.000 description 1
- DQGMPXYVZZCNDQ-NZVWDSLRSA-N (8E,10Z,12E)-octadeca-8,10,12-trienoic acid Chemical compound CCCCC\C=C\C=C/C=C/CCCCCCC(O)=O DQGMPXYVZZCNDQ-NZVWDSLRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-AVQMFFATSA-N (9E,12E)-octadeca-9,12-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 1
- 239000001195 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid Substances 0.000 description 1
- MMJZTSLHOIGZPU-DOFZRALJSA-N (9Z,12Z,15Z,18Z)-tetracosatetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O MMJZTSLHOIGZPU-DOFZRALJSA-N 0.000 description 1
- OTOSPSFTSJOWAM-XBIODWJFSA-N (E)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O.CCCCCCCC\C=C\CCCCCCCC(O)=O.CCCCCCCC\C=C\CCCCCCCC(O)=O OTOSPSFTSJOWAM-XBIODWJFSA-N 0.000 description 1
- JYDNQSLNPKOEII-BZSWNNBUSA-N (Z)-hexadec-9-enoic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O.CCCCCC\C=C/CCCCCCCC(O)=O JYDNQSLNPKOEII-BZSWNNBUSA-N 0.000 description 1
- DHEMVUXAYZGHFQ-QZOPMXJLSA-N (Z)-tetracos-15-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O DHEMVUXAYZGHFQ-QZOPMXJLSA-N 0.000 description 1
- VSLOIHHRIJJNOM-NHEMYYLISA-N (Z)-tetradec-9-enoic acid Chemical compound CCCC\C=C/CCCCCCCC(O)=O.CCCC\C=C/CCCCCCCC(O)=O VSLOIHHRIJJNOM-NHEMYYLISA-N 0.000 description 1
- XYOMMVNZIAGSMW-UHFFFAOYSA-N (prop-2-enoylamino)methyl propane-1-sulfonate Chemical class CCCS(=O)(=O)OCNC(=O)C=C XYOMMVNZIAGSMW-UHFFFAOYSA-N 0.000 description 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical compound C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-Propanediol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N 1,4-Butanediol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N 1-Hexanol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- NDZFNTHGIIQMQI-UHFFFAOYSA-N 1-benzylpyridin-1-ium Chemical compound C=1C=CC=C[N+]=1CC1=CC=CC=C1 NDZFNTHGIIQMQI-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- HOVGGYKQQBWGED-UHFFFAOYSA-N 1-butyl-2-heptadec-1-enyl-4,5-dihydroimidazole;prop-2-enoic acid Chemical compound OC(=O)C=C.CCCCCCCCCCCCCCCC=CC1=NCCN1CCCC HOVGGYKQQBWGED-UHFFFAOYSA-N 0.000 description 1
- POKOASTYJWUQJG-UHFFFAOYSA-M 1-butylpyridin-1-ium;chloride Chemical compound [Cl-].CCCC[N+]1=CC=CC=C1 POKOASTYJWUQJG-UHFFFAOYSA-M 0.000 description 1
- HJUPHPDWOUZDKH-UHFFFAOYSA-M 1-decylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+]1=CC=CC=C1 HJUPHPDWOUZDKH-UHFFFAOYSA-M 0.000 description 1
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 description 1
- AMFMJCAPWCXUEI-UHFFFAOYSA-M 1-ethylpyridin-1-ium;chloride Chemical compound [Cl-].CC[N+]1=CC=CC=C1 AMFMJCAPWCXUEI-UHFFFAOYSA-M 0.000 description 1
- QAIGYXWRIHZZAA-UHFFFAOYSA-M 1-methylpyridin-1-ium;chloride Chemical compound [Cl-].C[N+]1=CC=CC=C1 QAIGYXWRIHZZAA-UHFFFAOYSA-M 0.000 description 1
- OVIYAWWBKPWUOH-UHFFFAOYSA-M 1-octylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCC[N+]1=CC=CC=C1 OVIYAWWBKPWUOH-UHFFFAOYSA-M 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- IBOIUWAYPMADRC-UHFFFAOYSA-M 1-propylpyridin-1-ium;chloride Chemical compound [Cl-].CCC[N+]1=CC=CC=C1 IBOIUWAYPMADRC-UHFFFAOYSA-M 0.000 description 1
- UUIVKBHZENILKB-UHFFFAOYSA-N 2,2-Dibromo-2-cyanoacetamide Chemical compound NC(=O)C(Br)(Br)C#N UUIVKBHZENILKB-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2,6-dimethylheptan-4-one Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- PQHYOGIRXOKOEJ-UHFFFAOYSA-J 2-(1,2-dicarboxylatoethylamino)butanedioate Chemical class [O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O PQHYOGIRXOKOEJ-UHFFFAOYSA-J 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N 2-(2-Ethoxyethoxy)ethanol Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-Methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical class CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- QVHMSMOUDQXMRS-UHFFFAOYSA-N 2-[2-[2-(2-hydroxypropoxy)propoxy]propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)COC(C)CO QVHMSMOUDQXMRS-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1H-imidazole Chemical compound C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 description 1
- TZWGFNMVDVSAIW-UHFFFAOYSA-N 2-heptadec-1-enyl-1-hexyl-4,5-dihydroimidazole;prop-2-enoic acid Chemical compound OC(=O)C=C.CCCCCCCCCCCCCCCC=CC1=NCCN1CCCCCC TZWGFNMVDVSAIW-UHFFFAOYSA-N 0.000 description 1
- NQOZKOZINYDVGB-UHFFFAOYSA-N 2-heptadec-1-enyl-1-propyl-4,5-dihydroimidazole;prop-2-enoic acid Chemical compound OC(=O)C=C.CCCCCCCCCCCCCCCC=CC1=NCCN1CCC NQOZKOZINYDVGB-UHFFFAOYSA-N 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-L 2-sulfobutanedioate Chemical class OS(=O)(=O)C(C([O-])=O)CC([O-])=O ULUAUXLGCMPNKK-UHFFFAOYSA-L 0.000 description 1
- VZIHTQKMHLOIII-UHFFFAOYSA-N 3,5-dihydro-2H-furan Chemical group [CH]1CCOC1 VZIHTQKMHLOIII-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- YCLSOMLVSHPPFV-UHFFFAOYSA-N 3-(2-carboxyethyldisulfanyl)propanoic acid Chemical compound OC(=O)CCSSCCC(O)=O YCLSOMLVSHPPFV-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- BCFOOQRXUXKJCL-UHFFFAOYSA-M 4-amino-4-oxo-2-sulfobutanoate Chemical class NC(=O)CC(C([O-])=O)S(O)(=O)=O BCFOOQRXUXKJCL-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920000800 Acrylic rubber Polymers 0.000 description 1
- 229940045714 Alkyl sulfonate alkylating agents Drugs 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N Anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L Calcium hydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229960001927 Cetylpyridinium Chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M Cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N Cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 229960002433 Cysteine Drugs 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000605826 Desulfomicrobium Species 0.000 description 1
- 241000605716 Desulfovibrio Species 0.000 description 1
- CEJLBZWIKQJOAT-UHFFFAOYSA-N Dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000021300 Erucid acid Nutrition 0.000 description 1
- LZCLXQDLBQLTDK-UHFFFAOYSA-N Ethyl lactate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000007842 Glycine max Species 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N Glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 229940015043 Glyoxal Drugs 0.000 description 1
- 229940119837 Isopropyl Alcohol Drugs 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- LWXVCCOAQYNXNX-UHFFFAOYSA-N Lithium hypochlorite Chemical compound [Li+].Cl[O-] LWXVCCOAQYNXNX-UHFFFAOYSA-N 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L Magnesium hydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- MBKDYNNUVRNNRF-UHFFFAOYSA-N Medronic acid Chemical group OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 description 1
- 229960000282 Metronidazole Drugs 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- CFNHVUGPXZUTRR-UHFFFAOYSA-N N'-propylethane-1,2-diamine Chemical compound CCCNCCN CFNHVUGPXZUTRR-UHFFFAOYSA-N 0.000 description 1
- VJKGWQAUECALGS-UHFFFAOYSA-N OCCP(O)(=O)OP(O)=O Chemical compound OCCP(O)(=O)OP(O)=O VJKGWQAUECALGS-UHFFFAOYSA-N 0.000 description 1
- 229920001774 Perfluoroether Chemical group 0.000 description 1
- 229940023488 Pill Drugs 0.000 description 1
- 229920002319 Poly(methyl acrylate) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M Potassium bicarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M Potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- JHJLBTNAGRQEKS-UHFFFAOYSA-M Sodium bromide Chemical class [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N Sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M Stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- WMXCDAVJEZZYLT-UHFFFAOYSA-N Tert-Butylthiol Chemical compound CC(C)(C)S WMXCDAVJEZZYLT-UHFFFAOYSA-N 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-N Thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N Thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- YRIZYWQGELRKNT-UHFFFAOYSA-N Trichloroisocyanuric acid Chemical class ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N Triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N Triethylenetetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- NWGKJDSIEKMTRX-HSACVWGTSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate Chemical class CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-HSACVWGTSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- KBGYPXOSNDMZRV-PDBXOOCHSA-N all-cis-7,10,13-hexadecatrienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCC(O)=O KBGYPXOSNDMZRV-PDBXOOCHSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- FYPDLBRWCMAOHB-UHFFFAOYSA-O azanium;chloromethane Chemical compound [NH4+].ClC FYPDLBRWCMAOHB-UHFFFAOYSA-O 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004622 benzoxazinyl group Chemical group O1NC(=CC2=C1C=CC=C2)* 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 description 1
- BVCRERJDOOBZOH-UHFFFAOYSA-N bicyclo[2.2.1]heptanyl Chemical group C1C[C+]2CC[C-]1C2 BVCRERJDOOBZOH-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical group NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 230000003197 catalytic Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 125000004983 dialkoxyalkyl group Chemical group 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- XCCCPSSXVCKQLA-UHFFFAOYSA-L dodecyl(trimethyl)azanium;sulfate Chemical compound [O-]S([O-])(=O)=O.CCCCCCCCCCCC[N+](C)(C)C.CCCCCCCCCCCC[N+](C)(C)C XCCCPSSXVCKQLA-UHFFFAOYSA-L 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 238000004231 fluid catalytic cracking Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000003502 gasoline Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- BITHHVVYSMSWAG-KTKRTIGZSA-N gondoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- 229920000578 graft polymer Polymers 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- HYYHQASRTSDPOD-UHFFFAOYSA-N hydroxylamine;phosphoric acid Chemical class ON.OP(O)(O)=O HYYHQASRTSDPOD-UHFFFAOYSA-N 0.000 description 1
- 125000004282 imidazolidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])N([H])C1([H])* 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- OQFJYENCUVFMTB-UHFFFAOYSA-N methanamine;triazine Chemical compound NC.C1=CN=NN=C1 OQFJYENCUVFMTB-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M methanoate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 201000002674 obstructive nephropathy Diseases 0.000 description 1
- 125000005064 octadecenyl group Chemical group C(=CCCCCCCCCCCCCCCCC)* 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atoms Chemical group O* 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Chemical class 0.000 description 1
- 229920005652 polyisobutylene succinic anhydride Chemical class 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 230000000379 polymerizing Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- FEXQDZTYJVXMOS-UHFFFAOYSA-N propan-2-yl benzoate Chemical compound CC(C)OC(=O)C1=CC=CC=C1 FEXQDZTYJVXMOS-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 230000002829 reduced Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- UKNAYQWNMMGCNX-UHFFFAOYSA-N sodium;[hydroxy(phenyl)methyl]-oxido-oxophosphanium Chemical compound [Na+].[O-][P+](=O)C(O)C1=CC=CC=C1 UKNAYQWNMMGCNX-UHFFFAOYSA-N 0.000 description 1
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Chemical class 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- BSUNTQCMCCQSQH-UHFFFAOYSA-N triazine Chemical compound C1=CN=NN=C1.C1=CN=NN=C1 BSUNTQCMCCQSQH-UHFFFAOYSA-N 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- CAYKLJBSARHIDI-UHFFFAOYSA-K trichloroalumane;hydrate Chemical compound O.Cl[Al](Cl)Cl CAYKLJBSARHIDI-UHFFFAOYSA-K 0.000 description 1
- 125000006168 tricyclic group Chemical group 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
Abstract
Disclosed are biocide compositions. The compositions are useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed are methods of using the compositions, particularly in applications relating to the production, transportation, storage, and separation of crude oil and natural gas.
Description
The présent disclosure relates generally to biocides, and more particularly to biocides including an imidazoline (e.g., acrylated imidazoline), a quatemary amine, and a phosphonium compound (e.g., tetrakis-(hydroxymethyl) phosphonium sulfate).
BACKGROUND OF THE INVENTION
Oilfield Systems are subjected to increased risks associated with microbial control including: H2S production, microbial influenced corrosion (MIC) and biofouling. When MIC is suspected in a System, the main area of concem becomes the biofilm, or sessile organisms, on the surface of the pipeline. It is widely recognized, within the industry, that in order to be effective at controlling the bacteria within a System there should be a focus on minimizing biofilm regrowth kinetics following treatment (sessile control) in addition to providing sufficient planktonic kill. While tetrakis-(hydroxymethyl) phosphonium sulfate, glutaraldehyde, and quaternary ammonium compounds are widely used as biocides, their efficacy is limited when considering their ability to delay the regrowth kinetics of biofilms after biocide treatment. Thus, there is an increased need, in the oilfield industry, to provide microbial kill and biofilm control, and in particular, to penetrate and delay the regrowth kinetics of biofilms.
SUMMARY OF THE INVENTION
In one aspect, disclosed is a biocide composition including: an imidazoline compound; a quatemary amine; and a phosphonium compound.
The imidazoline compound has formula (I),
R' (!) wherein
R1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR6, -CO2R7, -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);
R is a radical derived from a fatty acid;
a
R is selected from a radical derived from an unsaturated acid;
R6, R7, Rs, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;
R and R are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; and
R14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
For compounds of formula (I), R1 can be unsubstituted C2-Cû-alkyl; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Cj-Cg-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
For compounds of formula (I), R1 can be linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31; R2 is -C17H35, -CI7H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
For compounds of formula (I), R1 can be linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2alkyl-CO2R17, wherein R17 is hydrogen or is absent; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
Further, the imidazoline compound can has formula (II),
R2
(H) wherein
R1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);
R2 is a radical derived from a fatty acid;
R3 and Rx are each independently selected from a radical derived from an unsaturated acid;
R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;
R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; and
R14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
For a compound of formula (2), R can be unsubstituted C2-C6-alkyl; R is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; Rx is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-C6-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
For a compound of formula (2), R1 can be linear C2-alkyl, substituted with one substituent that is a terminal -N(R )(R ), wherein R is hydrogen and R is -COR14, wherein R14 is -Ci7H35, -Q7H33, or -C17H3i; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cg-alkyl, or Re is absent; Rx is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
For a compound of formula (2), R1 can be linear C2-alkyl, substituted with one substituent that is a terminal -N(RI2)(R13), wherein R12 and R13 are each a -C2alkyl-CO2R17, wherein R17 is hydrogen or is absent; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cû-alkyl, or Re is absent; Rx is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
Additionally, the imidazoline compound can hâve a structure of formula (III), f
n^n^r1
(lll) wherein
R1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(Rw), -OR1 \ and -N(R12)(R13); '
R2 is a radical derived from a fatty acid;
R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;
R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; and
R14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
For compounds of formula (3), R can be unsubstituted C2-Cg-alkyl; R is -C17H35, -Ci7H33, or -CnH3i; R4 is hydrogen; and R5 is hydrogen.
For a compound of formula (3), R1 can be linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -ΟπΗ33, or -CnH3i; R2 is -C17H35, -Ci7H33, or -Ci7H3i; R4 is hydrogen; and R5 is hydrogen.
For a compound of formula (3), R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2alkyl-CO2R17, wherein R17 is hydrogen or is absent; R2 is -C17H35, -ΟπΗ33, or -Ci7H3i; R4 is hydrogen; and R5 is hydrogen.
The quatemary amine can hâve the formula [N+R5aR6aR7aR8a][X~] wherein
R5a, R6a, R7a, and R8a are each independently selected from substituted or unsubstituted Ci-Cjg-alkyl; and
X is Cl, Br or I.
For the quatemary amine, R5a, R6a, R7a, and R8a can each independently be selected from the group consisting of unsubstituted Cj-Cig-alkyl, Ci-Cjg-hydroxyalkyl, and benzyl.
The quatemary amine can be selected from the group consisting of tetramethyl ammonium chloride, tetraethyl ammonium chloride, tetrapropyl ammonium chloride, tetrabutyl ammonium chloride, tetrahexyl ammonium chloride, tetraoctyl ammonium chloride, benzyltrimethyl ammonium chloride, benzyltriethyl ammonium chloride, phenyltrimethyl ammonium chloride, phenyltriethyl ammonium chloride, cetyl benzyldimethyl ammonium chloride, hexadecyl trimethyl ammonium chloride, dimethyl Ci2-i6-alkyl benzyl ammonium chloride, monomethyl di-Ci2-i6-alkyl benzyl quatemary ammonium chloride, benzyl triethanolamine quatemary ammonium chloride, benzyl dimethylaminoethanolamine quatemary ammonium chloride, cocoalkyl dimethyl benzyl ammonium chloride, and combinations thereof.
The phosphonium compound can be selected from the group consisting of alkyltris(hydroxyorgano)phosphonium salts, alkenyltris(hydroxyorgano)phosphonium salts, tetrakis(hydroxyorgano)phosphonium salts, and combinations thereof.
Further, the phosphonium compound can be selected from the group consisting of Ci-C3-alkyltris(hydroxymethyl)phosphonium salts, C2-C3alkenyltris(hydroxymethyl)phosphonium salts, tetrakis(hydroxymethyl)phosphonium salts, and combinations thereof.
Additionally, the phosphonium compound can be selected from the group consisting of tetrakis(hydroxymethyl)phosphonium sulphate (THPS), tetrakis(hydroxymethyl)phosphonium chloride, tetrakis(hydroxymethyl)phosphonium phosphate, tetrakis(hydroxymethyl)phosphonium formate, tetrakis(hydroxymethyl)phosphonium acetate, tetrakis(hydroxymethyl)phosphonium oxalate, and combinations thereof.
The composition can further include a demulsifier. The demulsifier can be selected from the group consisting of dodecylbenzylsulfonic acid (DDBSA), the sodium sait of xylenesulfonic acid (NAXSA), epoxylated and propoxylated compounds, anionic cationic and nonionic surfactants, and resins, phenolic and epoxide resins, and combinations thereof.
The composition can further comprise one or more additional components, each component independently selected from the group consisting of corrosion inhibitors, solvents, asphaltene inhibitors, paraffin inhibitors, scale inhibitors, emulsifiers, water clarifiers, dispersants, gas hydrate inhibitors, biocides, pH modifiers, and surfactants.
In another aspect, disclosed is a method of controlling biofouling, the method comprising providing an effective amount of a composition of the invention into a System. The method can include controlling microbe prolifération in a System used in the production, transportation, storage, and séparation of crude oil and natural gas. The method can include controlling microbe prolifération in a System used in a coal-fired process, a waste-water process, a farm, a slaughter house, a land-fill, a municipality waste-water plant, a coking coal process, or a biofuel process.
The compounds, compositions, methods and processes are further described herein.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 depicts biocidal activity of compositions including a quatemary amine and an imidazoline.
Figure 2 depicts biocidal activity of compositions including one or more of an imidazoline, a quatemary amine, and a phosphonium sait.
Figure 3 depicts biocidal activity of compositions including varying ratios of imidazoline, quatemary amine, and phosphonium sait components.
Figure 4 depicts an émulsion tendency study.
Figures 5A, 5B, and 5C depict graphs of corrosion rate versus concentration for V08, THPS, and glutaraldehyde.
DETAILED DESCRIPTION
Disclosed herein are biocide compositions, methods of using said compositions, and processes for their préparation. The compositions include a synergistic combination of at least one imidazoline compound, at least one quatemary amine, and at least one phosphonium compound. The compositions can further include an émulsion breaker to facilitate oil/water séparation in the System being treated.
The compositions are particularly useful for controlling microbe prolifération in equipment used in the production, transportation, storage, and séparation of crude oil and natural gas. The compositions kill planktonic and sessile microorganisms and provide enhanced control of biofilm kinetic regrowth (sessile control). The compositions are effective against common oilfield microbes (e.g., sulfate reducing and acid producing bacteria), including généra such as Desulfovibrio, Desulfomicrobium, Shewanellci, Clostridium, and Pseudomonas, amongst others. The compositions thus reduce the required biocide treatment rate and treatment frequency compared to biocides currently on the market.
1. Définition of Terms
Unless otherwise defined, ail technical and scientific terms used herein hâve the same meaning as commonly understood by one of ordinary skill in the art. In case of conflict, the présent document, including définitions, will control. Preferred methods and materials are described below, although methods and materials similar or équivalent to those described herein can be used in practice or testing of the présent invention. Ail publications, patent applications, patents and other references mentioned herein are incorporated by reference in their entirety. The materials, methods, and examples disclosed herein are illustrative only and not intended to be limiting.
The terms “comprise(s),” “include(s),” “having,” “has,” “can,” “contain(s),” and variants thereof, as used herein, are intended to be open-ended transitional phrases, terms, or words that do not preclude the possibility of additional acts or structures. The singular forms “a,” “and” and “the” include plural references unless the context clearly dictâtes otherwise. The présent disclosure also contemplâtes other embodiments “comprising,” “consisting of ’ and “consisting essentially of,” the embodiments or éléments presented herein, whether explicitly set forth or not. The term “suitable substituent,” as used herein, is intended to mean a chemically acceptable functional group, preferably a moiety that does not negate the activity of the inventive compounds. Such suitable substituents include, but are not limited to halo groups, perfluoroalkyl groups, perfluoroalkoxy groups, alkyl groups, alkenyl groups, alkynyl groups, hydroxy groups, oxo groups, mercapto groups, alkylthio groups, alkoxy groups, aryl or heteroaryl groups, aryloxy or heteroaryloxy groups, aralkyl or heteroaralkyl groups, aralkoxy or heteroaralkoxy groups, HO—(C=O)—· groups, heterocylic groups, cycloalkyl groups, amino groups, alkyl - and dialkylamino groups, carbamoyl groups, alkylcarbonyl groups, alkoxycarbonyl groups, alkylaminocarbonyl groups, dialkylamino carbonyl groups, arylcarbonyl groups, aryloxycarbonyl groups, alkylsulfonyl groups, and arylsulfonyl groups. Those skilled in the art will appreciate that many substituents can be substituted by additional substituents.
The term “alkyl,” as used herein, refers to a linear or branched hydrocarbon radical, preferably having 1 to 32 carbon atoms (i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 39, 30, 31, or 32 carbons). Alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-butyl, secondary-butyl, and tertiary-butyl. Alkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “alkenyl,” as used herein, refers to a straight or branched hydrocarbon radical, preferably having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24,25, 26, 27, 28, 39, 30, 31, or 32 carbons, and having one or more carbon-carbon double bonds. Alkenyl groups include, but are not limited to, ethenyl, 1-propenyl, 2-propenyl (allyl), iso-propenyl, 2-methyl-l-propenyl, 1butenyl, and 2-butenyl. Alkenyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “alkynyl,” as used herein, refers to a straight or branched hydrocarbon radical, preferably having 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 39, 30, 31, or 32 carbons, and having one or more carbon-carbon triple bonds. Alkynyl groups include, but are not limited to, ethynyl, propynyl, and butynyl. Alkynyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “alkoxy,” as used herein, refers to an alkyl group, as defined herein, appended to the parent molecular moiety through an oxygen atom.
The term “aryl,” as used herein, means monocyclic, bicyclic, or tricyclic aromatic radicals such as phenyl, naphthyl, tetrahydronaphthyl, indanyl and the like; optionally substituted by one or more suitable substituents, preferably 1 to 5 suitable substituents, as defined above.
The term “arylalkyl,” as used herein, refers to an aryl group attached to the parent molecular moiety through an alkyl group. Arylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “alkylarylalkyl,” as used herein, refers to an alkylaryl group attached to the parent molecular moiety through an alkyl group. Alkylarylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above. The term “carbonyl,” “(C=O),” or “-C(O)-” (as used in phrases such as alkylcarbonyl, alkyl -(C=O)—· or alkoxycarbonyl) refers to the joinder of the >C=O moiety to a second moiety such as an alkyl or amino group (i.e. an amido group). Alkoxycarbonylamino (i.e. alkoxy(C=O)—NH—) refers to an alkyl carbamate group. The carbonyl group is also equivalently defined herein as (C=O). Alkylcarbonylamino refers to groups such as acetamide.
The term “cycloalkyl,” as used herein, refers to a mono, bicyclic or tricyclic carbocyclic radical (e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclopentenyl, cyclohexenyl, bicyclo[2.2.1]heptanyl, bicyclo[3.2.1]octanyl and bicyclo[5.2.0]nonanyl, etc.); optionally containing 1 or 2 double bonds. Cycloalkyl groups can be unsubstituted or substituted by one or more suitable substituents, preferably 1 to 5 suitable substituents, as defined above.
The term “cycloalkylalkyl,” as used herein, refers to a cycloalkyl group attached to the parent molecular moiety through an alkyl group. Cycloalkylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above. The term “alkylcycloalkylalkyl,” as used herein, refers to a cycloalkylalkyl group substituted by one or more alkyl groups. Alkylcycloalkylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “halo” or “halogen,” as used herein, refers to a fluoro, chloro, bromo or iodo radical.
The term “heteroaryl,” as used herein, refers to a monocyclic, bicyclic, or tricyclic aromatic heterocyclic group containing one or more heteroatoms (e.g., 1 to 3 heteroatoms) selected from O, S and N in the ring(s). Heteroaryl groups include, but are not limited to, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, thienyl, furyl, imidazolyl, pyrrolyl, oxazolyl (e.g., 1,3-oxazolyl, 1,2-oxazolyl), thiazolyl (e.g., 1,2-thiazolyl, 1,3-thiazolyl), pyrazolyl, tetrazolyl, triazolyl (e.g., 1,2,3-triazolyl, 1,2,4-triazolyl), oxadiazolyl (e.g., 1,2,3-oxadiazolyl), thiadiazolyl (e.g., 1,3,4thiadiazolyl), quinolyl, isoquinolyl, benzothienyl, benzofuryl, and indolyl. Heteroaryl groups can be unsubstituted or substituted by one or more suitable substituents, preferably 1 to 5 suitable substituents, as defined above.
The term “heteroarylalkyl,” as used herein, refers to a heteroaryl group attached to the parent molecular moiety through an alkyl group. Heteroarylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above. The term “alkylheteroarylalkyl,” as used herein, refers to a heteroarylalkyl group substituted by one or more alkyl groups. Alkylheteroarylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above. The tenu “heterocycle” or “heterocyclyl,” as used herein, refers to a monocyclic, bicyclic, or tricyclic group containing 1 to 4 heteroatoms selected from N, O, S(O)n, P(O)n, PRZ, NH or NRZ, wherein Rz is a suitable substituent. Heterocyclic groups optionally contain 1 or 2 double bonds. Heterocyclic groups include, but are not limited to, azetidinyl, tetrahydrofuranyl, imidazolidinyl, pyrrolidinyl, piperidinyl, piperazinyl, oxazolidinyl, thiazolidinyl, pyrazolidinyl, thiomorpholinyl, tetrahydrothiazinyl, tetrahydro-thiadiazinyl, morpholinyl, oxetanyl, tetrahydrodiazinyl, oxazinyl, oxathiazinyl, indolinyl, isoindolinyl, quinuclidinyl, chromanyl, isochromanyl, and benzoxazinyl. Examples of monocyclic saturated or partially saturated ring Systems are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, imidazolidin-l-yl, imidazolidin-2-yl, imidazolidin-4-yl, pyrrolidin-l-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, piperidin-l-yl, piperidin-2-yl, piperidin-3-yl, piperazin-l-yl, piperazin-2-yl, piperazin-3-yl, l,3-oxazolidin-3-yl, isothiazolidine, l,3-thiazolidin-3-yl, 1,2-pyrazolidin-2-yl, 1,3-pyrazolidin-l-yl, thiomorpholin-yl, 1,2-tetrahydrothiazin-2-yl, 1,3-tetrahydrothiazin-3-yl, tetrahydrothiadiazin-yl, morpholin-yl, l,2-tetrahydrodiazin-2-yl, 1,3tetrahydrodiazin-l-yl, l,4-oxazin-2-yl, and l,2,5-oxathiazin-4-yl. Heterocyclic groups can be unsubstituted or substituted by one or more suitable substituents, preferably 1 to 3 suitable substituents, as defined above.
The term “heterocyclylalkyl,” as used herein, refers to a heterocycle group attached to the parent molecular moiety through an alkyl group. Heterocyclylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “alkylheterocyclylalkyl,” as used herein refers to a heterocyclylalkyl group substituted by one or more alkyl groups. Alkylheterocyclylalkyl groups can be unsubstituted or substituted by one or more suitable substituents, as defined above.
The term “hydroxy,” as used herein, refers to an -OH group.
The term “oxo,” as used herein, refers to a double bonded oxygen (=0) radical wherein the bond partner is a carbon atom. Such a radical can also be thought as a carbonyl group.
The term “acrylate,” as used herein, refers to the material resulting from the Michael addition of acrylic acid to an imidazoline. The addition of this chemical moiety to the imidazoline increases its water solubility, enabling it to reach métal surfaces which are submerged beneath an aqueous layer.
The term “TOFA,” as used herein, refers to a tall oil fatty acid that is a distilled product derived from trees and includes a mixture of fatty acids, C17H31-35 COOH with a CAS No. 61790-12-3. It is a mixture of oleic acid as a major component, linoleic acid and saturated fatty acids (e.g., about 46% oleic acid, about 41% linoleic acid, about 4% stearic acid, and about 9% other acids).
The term “decyl”, as used herein, means a -C10H21 alkyl radical, also referred to as “capryl”.
The term “dodecyl”, as used herein, means a -Ci?H25 alkyl radical, also referred to as “lauryl”.
The term “hexadecyl”, as used herein, means a -C16H33 alkyl radical, also referred to as “palmityl”.
The term “hexyl”, as used herein, means a -C6H13 alkyl radical, also referred to as “caproyl”.
The term “octadecadienyl”, as used herein, means a cis,cis-9,12-octadecadienyl radical, also referred to as “linoleyl”.
The term “octadecenyl”, as used herein, means a cis-9-octadecenyl radical, also referred to as “oleyl”.
The term “octadecyl”, as used herein, means a -Ci8H37 alkyl radical, also referred to as “stearyl”.
The term “octyl”, as used herein, means a -CgHn alkyl radical, also referred to as “caprylyl.”
The term “tetradecyl”, as used herein, means a -C14H29 alkyl radical, also referred to as “myristyl”.
The term “myristoleic acid” or “(Z)-tetradec-9-enoic acid,” as used herein, refers to
O
The term “palmitoleic acid” or “(Z)-hexadec-9-enoic acid,” as used herein, refers to
The term “sapienic acid” or “(Z)-hexadec-ô-enoic acid,” as used herein, refers to
The term “elaidic acid” or “(E)-octadec-9-enoic acid,” as used herein, refers to
The term “vaccenic acid” or “(E)-octadec-l 1-enoic acid,” as used herein, refers to
The term “linoleic acid” or “(9Z,12Z)-octadeca-9,12-dienoic acid,” as used herein, refers to
The term “linoelaidic acid” or “(9E,12E)-octadeca-9,12-dienoic acid,” as used herein, refers to
The term “α-linolenic acid” or “(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid,” as used herein, refers to
O
The term “arachidonic acid” or “(5Z,8Z,1 lZ,14Z)-icosa-5,8,l 1,14-tetraenoic acid,” as used herein, refers to
O
The term “eicosapentaenoic acid” or “(5Z,8Z,1 lZ,14Z,17Z)-icosa-5,8,l 1,14,17pentaenoic acid,” as used herein, refers to
O
The term “erucic acid” or “(Z)-docos-13-enoic acid,” as used herein, refers to
The term “docosahexaenoic acid” or “(4Z,7Z,10Z,13Z,16Z,19Z)-docosa4,7,10,13,16,19-hexaenoic acid,” as used herein, refers to
O
The term “hexadecatrienoic acid” or “(7Z,10Z,13Z)-hexadeca-7,10,13-trienoic acid,” as used herein, refers to
O
The term “stearidonic acid” or “(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid,” as used herein, refers to
O
The term “eicosatrienoic acid” or “(1 lZ,14Z,17Z)-icosa-l 1,14,17-trienoic acid,” as used herein, refers to
The term “eicosatetraenoic acid” or “(5Z,8Z,1 lZ,14Z,17Z)-icosa-5,8,l 1,14,17pentaenoic acid,” as used herein, refers to
O
The term “heneicosapentaenoic acid” or “(6Z,9Z,12Z,15Z,18Z)-henicosa6,9,12,15,18-pentaenoic acid,” as used herein, refers to
O
The term “clupanodonic acid” or “(7Z, 10Z,13Z,l 6Z,19Z)-docosa-7,10,13,16,19pentaenoic acid,” as used herein, refers to
The term “osbond acid” or “(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid,” as used herein, refers to
The term “(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoic acid,” as used herein, refers to
The term “nisinic acid” or “(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21hexaenoic acid,” as used herein, refers to
O
The term “γ-linolenic acid” or “(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid,” as used herein, refers to
O
The term “eicosadienoic acid” or “(1 lZ,14Z)-icosa-l 1,14-dienoic acid,” as used herein, refers to
The term “dihomo-y-linolenic acid” or “(8Z,1 lZ,14Z)-icosa-8,l 1,14-trienoic acid,” as used herein, refers to
The term “docosadienoic acid” or “(13Z,16Z)-docosa-13,16-dienoic acid,” as used herein, refers to
The term “adrenic acid” or “(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoic acid,” as used herein, refers to
The term “tetracosatetraenoic acid” or “(9Z, 12Z,15Z,18Z)-tetracosa-9,12,15,18tetraenoic acid,” as used herein, refers to
The term “(6Z,9Z,12Z,15Z,18Z)-tetracosa-6,9,12,15,18-pentaenoic acid,” as used herein, refers to
The term “(Z)-Eicos-l 1-enoic acid” or “(Z)-icos-l 1-enoic acid,” as used herein, refers to
The term “paullinic acid” or “(Z)-icos-13-enoic acid,” as used herein, refers to
The term “mead acid” or “(5Z,8Z,1 lZ)-Eicosa-5,8,l 1-trienoic acid,” as used herein, refers to
The term “nervonic acid,” or “(Z)-tetracos-15-enoic acid,” as used herein, refers to
O
The term “rumenic acid” or “(9Z,1 lE)-octadeca-9,l 1-dienoic acid,” as used herein, refers to
The term “α-calendic acid” or “(8E,10E,12Z)-octadeca-8,10,12-trienoic acid,” as used herein, refers to
The term “β-calendic acid” or “(8E,10E,12E)-octadeca-8,10,12-trienoic acid,” as used herein, refers to
The term “jacaric acid” or “(8E,10Z,12E)-octadeca-8,10,12-trienoic acid,”
The term “a-eleostearic acid” or “(9Z,1 lE,13E)-octadeca-9,l 1,13-trienoic acid,” as used herein, refers to
The term “β-eleostearic acid” or “(9E,1 lE,13E)-octadeca-9,l 1,13-trienoic acid,” as used herein, refers to
The term “catalpic acid” or “(9E,1 lE,13Z)-octadeca-9,l 1,13-trienoic acid,” as used herein, refers to
The term “punicic acid” or “(9Z,1 lE,13Z)-octadeca-9,l 1,13-trienoic acid,” as used herein, refers to
The tenu “rumelenic acid” or “(9E,1 lZ,15E)-octadeca-9,l 1,15-trienoic acid,” as used herein, refers to
O
The term “a-parinaric acid” or “(9Z,1 lE,13E,15Z)-octadeca-9,l 1,13,15-tetraenoic acid,” as used herein, refers to
O
The term “β-parinaric acid” or “(9E,1 lE,13E,15E)-octadeca-9,l 1,13,15-tetraenoic acid,” as used herein, refers to
O
The term “bosseopentaenoic acid” or “(5Z,8Z,10E,12E,14Z)-icosa-5,8,10,12,14pentaenoic acid,” as used herein, refers to
The term “pinolenic acid” or “(5Z,9Z,12Z)-octadeca-5,9,12-trienoic acid,” as used herein, refers to
O
The term “podocarpic acid” or “(5Z,1 lZ,14Z)-icosa-5,l 1,14-trienoic acid,” as used herein, refers to
O
The term “propionic acid,” as used herein, refers to CH3CH2COOH.
The term “butyric acid,” as used herein, refers to CH3(CH2)2COOH.
The term “valeric acid,” as used herein, refers to CH3(CH2)3COOH.
The term “caproic acid,” as used herein, refers to CH3(CH2)4COOH.
The term “enanthic acid,” as used herein, refers to CE^CEysCOOH.
The term “caprylic acid,” as used herein, refers to CH3(CH2)6COOH.
The term “pelargonic acid,” as used herein, refers to CH3(CH2)7COOH.
The terni “capric acid,” as used herein, refers to CH3(CH2)8COOH.
The term “undecylic acid,” as used herein, refers to CH3(CH2)9COOH.
The term “lauric acid,” as used herein, refers to CH3(CH2)ioCOOH.
The term “tridecylic acid,” as used herein, refers to CH3(CH2)nCOOH.
The term “myristic acid,” as used herein, refers to CH3(CH2)i2COOH.
The term “pentadecylic acid,” as used herein, refers to CH3(CH2)i3COOH.
The term “palmitic acid,” as used herein, refers to CH^CH^uCOOH.
The term “margaric acid,” as used herein, refers to CH3(CH2)i5COOH.
The term “stearic acid,” as used herein, refers to CH3(CH2)i6COOH.
The term “nonadecylic acid,” as used herein, refers to CH3(CH2)i7COOH.
The term “arachidic acid,” as used herein, refers to CH3(CH2)isCOOH.
The term “heneicosylic acid,” as used herein, refers to CH3(CH2)i9COOH.
The term “behenic acid,” as used herein, refers to CH3(CH2)2ûCOOH.
The term “tricosylic acid,” as used herein, refers to CH3(CH2)2iCOOH.
The term “lignoceric acid,” as used herein, refers to CHXCH^hsCOOH.
The term “pentacosylic acid,” as used herein, refers to CH3(CH2)23COOH.
The term “cerotic acid,” as used herein, refers to CH3(CH2)24COOH.
The term “heptacosylic acid,” as used herein, refers to CH3(CH2)25COOH.
The term “montanic acid,” as used herein, refers to CH3(CH2)26COOH.
The term “nonacosylic acid,” as used herein, refers to CHaCCHthïCOOH.
The term “melissic acid,” as used herein, refers to CH^CE^hsCOOH.
The term “henatriacontylic acid,” as used herein, refers to CH3(CH2)29COOH.
The term “lacceroic acid,” as used herein, refers to CH3(CH2)3oCOOH.
The term “psyllic acid,” as used herein, refers to CH3(CH2)3iCOOH.
The term “geddic acid,” as used herein, refers to CH3(CH2)32COOH.
The term “ceroplastic acid,” as used herein, refers to CH3(CH2)33COOH.
The term “hexatriacontylic acid,” as used herein, refers to CH3(CH2)34COOH.
2. Compositions
The compositions disclosed herein include an imidazoline compound, a quatemary amine, and a phosphonium compound. The compositions can further include a demulsifer. The compositions can further include a synergist. The compositions can further include a solvent. The compositions can further include one or more additional components.
The composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, and a demulsifier.
Further, the composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, a demulsifier, and a synergist.
Additionally, the composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, a demulsifier, and a solvent.
Yet further, the composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, and a solvent.
Additionally, the composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, a synergist, and a solvent.
Further, the composition can include an imidazoline compound, a quatemary amine, a phosphonium compound, a demulsifier, a synergist, and a solvent.
a. Imidazoline Compounds
The compositions disclosed herein include at least one imidazoline compound.
The imidazoline compound can hâve formula (I), (II), or (III),
R2 | R2 | R2 |
r~n^n-r1 | 3 1 'RX | nÀn^r |
M | )—( | |
R4 R5 | R4 R5 | R4 R5 |
(l) | (H) | (III) |
wherein |
R1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);
R2 is a radical derived from a fatty acid;
R3 and Rx are each independently selected from a radical derived from an unsaturated acid;
R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;
R and R are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; and
R14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
For these imidazolines, R groups of carboxylic acid moieties can be absent where the R=H and the carboxylic acid moiety is deprotonated. For example, R15 and/or R can be absent where the R and/or R is a deprotonated carboxylic acid moiety (e.g., where R12 is -CH2CH2CO2’).
For an imidazoline compound, R1 can be unsubstituted alkyl. For example, R1 can be unsubstituted Cj-Cio-alkyl (e.g., methyl, ethyl, propyl (e.g., n-propyl, isopropyl), butyl (e.g., zz-butyl, isobutyl, ierAbutyl, sec-butyl), pentyl (e.g., npentyl, isopentyl, teri-pentyl, neopentyl, sec-pentyl, 3-pentyl), hexyl, heptyl, octyl, nonyl, or decyl). Further, R1 can be unsubstituted C2-Cio-alkyl. For these imidazoline compounds, R1 can be unsubstituted C2-C8-alkyl. Further, R1 can be unsubstituted C2-C6-alkyl. Preferably, R1 is propyl, butyl, or hexyl.
For these imidazolines, R1 is substituted alkyl. For example, R1 is substituted CjCio-alkyl, substituted C2-Cio-alkyl, substituted C2-Cs-alkyl, or substituted C2-C6alkyl. Further, R1 is Cj-Cio-alkyl, C2-Cio-alkyl, C2-Cg-alkyl, or C2-C6-alkyl, substituted with one substituent selected from -COR6, -CO2R7, -SO3R8, -PO3H2, CON(R9)(R10), -OR11, and -N(R12)(R13), wherein R6, R7, R8, R9, R10, R11, R12, and R are as defined above. More specifïcally, R is C2-C6-alkyl, substituted with one substituent selected from -N(R )(R ), wherein R and R are each independently selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17, wherein R14, R15, R16, and R17 are as defined above. Further, R1 is C2-Cô-alkyl, substituted with one substituent selected from -N(R )(R ), wherein R12 and R13 are each independently selected from hydrogen, C2-C6-alkyl, -COR14, CO2R15, -C2-C6-alkyl-COR16, and -C2-C6-alkyl-CO2R17, wherein R14, R15, R16, and R are selected from hydrogen and Ci-C34-alkyl. For these imidazolines, R is linear C2-C6-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each independently selected from hydrogen, -COR14, -CO2R15, -C2-C6-alkyl-COR16, and -C2-C6-alkyl-CO2R17, wherein R14, R15, R16, and R17 are selected from hydrogen and Ci-C34-alkyl. For example, R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31. Further, R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen.
For the imidazolines of formulae (I), (II), and (III), R2 is C4-C34-alkyl or C4-C34alkenyl. For example, R2 is -(CH2)3CH3; -(CH2)4CH3; -(CH2)5CH3; -(CH2)6CH3; -(CH2)7CH3; -(CH2)8CH3; -(CH2)9CH3; -(CH2)1oCH3; -(CH2)1iCH3; -(CH2)12CH3; -(CH2)I3CH3; -(CH2)14CH3; -(CH2)i5CH3; -(CH2)i6CH3; -(CH2)I7CH3; -(CH2)i8CH3; -(CH2)19CH3; -(CH2)20CH3; -(CH2)2ICH3; -(CH2)22CH3; -(CH2)23CH3; -(CH2)24CH3; -(CH2)25CH3; -(CH2)26CH3; -(CH2)27CH3; -(CH2)28CH3; -(CH2)29CH3; -(CH2)30CH3; -(CH2)31CH3; -(CH2)32CH3; -(CH2)33CH3; -(CH2)34CH3;
-(CH2)2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH 2CH3;-(CH2)3CH=CHCH2CH=CHCH2CH==CH(CH2)7CH3;
-(CH2)3CH=CHCH2CH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)3CH=CH(CH2)4CH=CHCH2CH=CH(CH2)4CH3; -(CH2)3CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)3CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3; -(CH2)3CH=CHCH=CHCH=CHCH=CHCH=CH(CH2)4CH3;
-(CH2)4CH=CH(CH2)8CH3;-(CH2)4CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3 ; -(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH 2CH3;-(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3; -(CH2)6CH=CHCH=CHCH=CH(CH2)4CH3;
-(CH2)6CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)7CH=CH(CH2)3CH3;-(CH2)7CH=CH(CH2)5CH3;
-(CH2)7CH=CH(CH2)7CH3;-(CH2)7CH=CHCH=CHCH=CH(CH2)3CH3; -(CH2)7CH=CHCH=CH(CH2)5CH3;-(CH2)7CH=CHCH2CH=CH(CH2)4CH3; -(CH2)7CH=CHCH2CH=CH(CH2)4CH3 ;
-(CH2)7CH=CHCH=CHCH2CH2CH=CHCH2CH3; -(CH2)7CH=CHCH-CHCH=CHCH-CHCH2CH3; -(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3; -(CH2)9CH=CH(CH2)5CH3;-(CH2)9CH=CHCH2CH=CH(CH2)4CH3; -(CH2)9CH=CHCH2CH=CHCH2CH=CHCH2CH3;-(CH2)9CH=CH(CH2)7CH3; -(CH2)i iCH=CH(CH2)5CH3; -(CH2)hCH=CH(CH2)7CH3;
-(CH2)hCH=CHCH2CH=CH(CH2)4CH3; or -(CH2)i3CH=CH(CH2)7CH3.
For the imidazolines, R2 can be a radical derived from a saturated or unsaturated fatty acid. Suitable saturated fatty acids include, but are not limited to, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, palmitic acid, margaric acid, stearic acid, nonadecylic acid, arachidic acid, heneicosylic acid, behenic acid, tricosylic acid, lignoceric acid, pentacosylic acid, cerotic acid, heptacosylic acid, montanic acid, nonacosylic acid, melissic acid, henatriacontylic acid, lacceroic acid, psyllic acid, geddic acid, ceroplastic acid, and hexatriacontylic acid. Suitable unsaturated fatty acids include, but are not limited to, myristoleic acid, palmitoleic acid, sapienic acid, oleic acid, elaidic acid, vaccenic acid, linoleic acid, linoelaidic acid, α-linolenic acid, arachidonic acid, eicosapentaenoic acid, erucic acid, docosahexaenoic acid, hexadecatrienoic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, heneicosapentaenoic acid, clupanodonic acid, osbond acid, (9Z,12Z,15Z,18Z,21Z)-tetracosa9,12,15,18,21-pentaenoic acid, nisinic acid, γ-linolenic acid, eicosadienoic acid, dihomo-y-linolenic acid, docosadienoic acid, adrenic acid, tetracosatetraenoic acid, (6Z,9Z,12Z,15Z,18Z)-tetracosa-6,9,12,15,18-pentaenoic acid, (Z)-Eicos-11-enoic acid, mead acid, erucic acid, nervonic acid, rumenic acid, α-calendic acid, βcalendic acid, jacaric acid, α-eleostearic acid, β-eleostearic acid, catalpic acid, punicic acid, rumelenic acid, α-parinaric acid, β-parinaric acid, bosseopentaenoic acid, pinolenic acid, and podocarpic acid. Preferably, R2 is derived from coconut oil, beef tallow, or tall oil fatty acids (TOFA).
For the imidazoline, R3 is -C(RaRb)-C(RcRd)-CO2Re, wherein Ra, Rb, Rc, and Rd are each independently selected from the group consisting of hydrogen (-H), halogen, and alkyl, and wherein Re is hydrogen (-H) or alkyl. For example, R3 is -C(RaRb)C(RcRd)-CO2Re, wherein Ra, Rb, Rc, and Rd are each independently selected from the group consisting of hydrogen (-H), halogen, and Ci-Cg-alkyl, and wherein Re is hydrogen (-H) or Ci-Cg-alkyl. Further, R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H) or Cj-Cg-alkyl. Additionally, Re can be absent where the R3 is a deprotonated carboxylic acid moiety (e.g., where R3 is -CH2CH2CO2').
For the imidazolines, R3 can be derived from an acrylic acid. Suitable acrylic acids include, but are not limited to, acrylic acid, methacrylic acid, 2-ethylacrylic acid, 2propylacrylic acid, and 2-(trifluoromethyl)acrylic acid. For example, R3 can be derived from acrylic acid (H2C=CHCO2H).
Imidazolines of formulae (I), (II), or (III) can hâve Rx is -C(RaRb)-C(RcRd)-CO2Re, wherein Ra, Rb, Rc, and Rd are each independently selected from the group consisting of hydrogen (-H), halogen, and alkyl, and wherein Re is hydrogen (-H) or alkyl. Further, Rx can be -C(RaRb)-C(RcRd)-CO2Re, wherein Ra, Rb, Rc, and Rd are each independently selected from the group consisting of hydrogen (-H), halogen, and Ci-Cô-alkyl, and wherein Re is hydrogen (-H) or Cj-Cô-alkyl. Additionally, Rx is -CH2CH2CO2Re, wherein Re is hydrogen (-H) or Ci-Cô-alkyl. Further, Re can be absent where the Rx is a deprotonated carboxylic acid moiety (e.g., where Rx is -CH2CH2CO2').
For the imidazolines described herein, Rx can be derived from an acrylic acid. Suitable acrylic acids include, but are not limited to, acrylic acid, methacrylic acid, 2-ethylacrylic acid, 2-propylacrylic acid, and 2-(trifluoromethyl)acrylic acid. For example, Rx can be derived from acrylic acid (H2C=CHCO2H).
Imidazolines of formulae (I), (II), or (III) can hâve R4 and R5 each independently be an unsubstituted Ci-Cio-alkyl (e.g., methyl, ethyl, propyl (e.g., n-propyl, isopropyl), butyl (e.g., n-butyl, isobutyl, terAbutyl, 5ec-butyl), pentyl (e.g., npentyl, isopentyl, ierApentyl, neopentyl, sec-pentyl, 3-pentyl), hexyl, heptyl, octyl, nonyl, or decyl) or hydrogen. Further, R4 and R5 can each independently be an unsubstituted Ci-Cg alkyl group or hydrogen. Preferably, R4 and R5 are each hydrogen (-H).
Imidazolines of formulae (I), (II), or (III) can hâve R6, R7, R8, R9, R10, and R11 each independently be, at each occurrence, selected from hydrogen, unsubstituted alkyl, and unsubstituted alkenyl. For example, R6, R7, R8, R9, R10, and R11 can each independently be, at each occurrence, selected from hydrogen, unsubstituted CiC34-alkyl, and unsubstituted C2-C34-alkenyl. Further, R6, R7, R8, R9, R10, and R11 can each independently be, at each occurrence, selected from hydrogen, unsubstituted Ci-Cio-alkyl, and unsubstituted C2-Cio-alkenyl.
Further, R6, R7, R8, R9, R10, and R11 can each independently be, at each occurrence, selected from hydrogen, and a radical derived from a fatty acid.
For the imidazoline compounds, R12 and R13 can each independently be, at each occurrence, selected from hydrogen, Ci-Cio-alkyl, -COR14, -CO2R15, -Ci-Cioalkyl-COR16, and -Ci-Ci0-alkyl-CO2R17. Further, R12 and R13 can each independently be, at each occurrence, selected from hydrogen, unsubstituted CiCio-alkyl, -COR14, -CO2R15, -Cj-Cio-alkyl-COR16, and -Ci-C10-alkyl-CO2R17. For the imidazolines, R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen, unsubstituted alkyl, and unsubstituted alkenyl. Further, R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen, unsubstituted Ci-C34-alkyl, and unsubstituted C2-C34alkenyl. Additionally, R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen, unsubstituted Cj-Cio-alkyl, and unsubstituted C2-Cio-alkenyl. Further, R and/or R can be absent where the carboxylic acid moiety is deprotonated.
Imidazoline compounds can hâve R14, R15, R16, and R17 each independently be, at each occurrence, selected from hydrogen, and a radical derived from a fatty acid. Further, R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen, C4-C34-alkyl, and C4-C34-alkenyl. Additionally, R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen; -(CH2)3CH3; -(CH2)4CH3; -(CH2)5CH3; -(CH2)6CH3; -(CH2)7CH3; -(CH2)8CH3; -(CH2)9CH3; -(CH2)i0CH3; -(CH2)hCH3; -(CH2)12CH3; -(CH2)i3CH3; -(CH2)14CH3; -(CH2)i5CH3; -(CH2)16CH3; -(CH2)i7CH3; -(CH2)18CH3; -(CH2)i9CH3; -(CH2)20CH3; -(CH2)2iCH3; -(CH2)22CH3; -(CH2)23CH3;
-(CH2)24CH3; -(CH2)25CH3; -(CH2)26CH3; -(CH2)27CH3; -(CH2)28CH3j
-(CH2)29CH3; -(CH2)30CH3; -(CH2)31CH3; -(CH2)32CH3; -(CH2)33CH3;
-(CH2)34CH3;
-(CH2)2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)2CH=CHCH2CH=CHCH2CH=CHCH2CH-CHCH2CH=CHCH2CH=CHCH 2CH3; -(CH2)3CH=CHCH2CH=CHCH2CH=CH(CH2)7CH3;
-(CH2)3CH=CHCH2CH2CH=CHCH2CH==CH(CH2)4CH3;
-(CH2)3CH=CH(CH2)4CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)3CH-CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)3CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)3CH=CHCH=CHCH=CHCH=CHCH=CH(CH2)4CH3;
-(CH2)4CH=CH(CH2)8CH3;-(CH2)4CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3; -(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3; -(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH 2CH3;-(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)5CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3; -(CH2)6CH=CHCH=CHCH=CH(CH2)4CH3;
-(CH2)6CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3j -(CH2)7CH=CH(CH2)3CH3;-(CH2)7CH=CH(CH2)5CH3;
-(CH2)7CH=CH(CH2)7CH3;-(CH2)7CI-I=CHCH=CHCH=CH(CH2)3CH3;
-(CH2)7CH=CHCH=CH(CH2)5CH3;-(CH2)7CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)7CH=CHCH2CH=CH(CH2)4CH3 ;
-(CH2)7CH=CHCH=CHCH2CH2CH=CHCH2CH3;
-(CH2)7CH=CHCH=CHCH=CHCH=CHCH2CH3;
-(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)7CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH3;
-(CH2)9CH=CH(CH2)5CH3;-(CH2)9CH=CHCH2CH=CH(CH2)4CH3;
-(CH2)9CH=CHCH2CH=CHCH2CH=CHCH2CH3;-(CH2)9CH=CH(CH2)7CH3;
-(CH2)1iCH=CH(CH2)5CH3;-(CH2)iiCH=CH(CH2)7CH3; -(CH2)hCH=CHCH2CH=CH(CH2)4CH3; and -(CH2)i3CH=CH(CH2)7CH3. For the imidazolines of formulae (I), (II), and (III), R14, R15, R16, and R17 can each independently be, at each occurrence, selected from hydrogen, a radical derived from a saturated fatty acid, and a radical derived from an unsaturated fatty acid. Suitable saturated fatty acids include, but are not limited to, butyric acid, valeric acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, palmitic acid, margaric acid, stearic acid, nonadecylic acid, arachidic acid, heneicosylic acid, behenic acid, tricosylic acid, lignoceric acid, pentacosylic acid, cerotic acid, heptacosylic acid, montante acid, nonacosylic acid, melissic acid, henatriacontylic acid, lacceroic acid, psyllic acid, geddic acid, ceroplastic acid, and hexatriacontylic acid. Suitable unsaturated fatty acids include, but are not limited to, myristoleic acid, palmitoleic acid, sapienic acid, oleic acid, elaidic acid, vaccenic acid, linoleic acid, linoelaidic acid, α-linolenic acid, arachidonic acid, eicosapentaenoic acid, erucic acid, docosahexaenoic acid, hexadecatrienoic acid, stearidonic acid, eicosatrienoic acid, eicosatetraenoic acid, heneicosapentaenoic acid, clupanodonic acid, osbond acid, (9Z,12Z,15Z,18Z,21Z)-tetracosa9,12,15,18,21-pentaenoic acid, nisinic acid, γ-linolenic acid, eicosadienoic acid, dihomo-y-linolenic acid, docosadienoic acid, adrenic acid, tetracosatetraenoic acid, (6Z,9Z,12Z,15Z,18Z)-tetracosa-6,9,12,15,18-pentaenoic acid, (Z)-Eicos-l 1-enoic acid, mead acid, erucic acid, nervonic acid, rumenic acid, α-calendic acid, βcalendic acid, jacaric acid, α-eleostearic acid, β-eleostearic acid, catalpic acid, punicic acid, rumelenic acid, α-parinaric acid, β-parinaric acid, bosseopentaenoic acid, pinolenic acid, and podocarpic acid. Further, R14, R15, R16, and R17 are each independently, at each occurrence, hydrogen or a radical derived from coconut oil, beef tallow, or tall oil fatty acids (TOFA).
Preferably, the imidazoline is a compound of formula (I), wherein R1 is unsubstituted C2-Cô-alkyl; R2 is -Cj7H35, -Ci7H33, or -Ci7H3i; R3 is CH2CH2CO2Re, wherein Re is hydrogen (-H), Cj-Cô-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2’); R4 is hydrogen; and R5 is hydrogen.
Altematively, the imidazoline is a compound of formula (I), wherein R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(RI2)(R13), wherein
R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (H), Cj-Cg-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2’); R4 is hydrogen; and R5 is hydrogen.
Further, the imidazoline is a compound of formula (I), wherein R1 is linear C2alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R are each a -C2-alkyl-CO2R , wherein R is hydrogen or is absent (e.g., R12 is -C2-alkyl-CO2·); R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Ci-Cô-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2' ); R4 is hydrogen; and R5 is hydrogen.
Additionally, the imidazoline is a compound of formula (II), wherein R1 is unsubstituted C2-C6-alkyl; R2 is -C17H35, -C17H33, or -C17H31; R3 is CH2CH2CO2R6, wherein Re is hydrogen (-H), Ci-Cg-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2·); Rx is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Ci-C6-alkyl, or Re is absent (e.g., Rx is -CH2CH2CO2'); R4 is hydrogen; and R5 is hydrogen. The imidazoline can be a compound of formula (II), wherein R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R )(R ), wherein R is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31; R2 is C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Cl-C6-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2·); Rx is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Cj-Cô-alkyl, or Re is absent (e.g., Rx is -CH2CH2CO2' ); R4 is hydrogen; and R5 is hydrogen.
The imidazoline can be a compound of formula (II), wherein R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R )(R ), wherein R and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen or is absent (e.g., R12 is C2-alkyl-CO2'); R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Cj-Cô-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2’); Rx is CH2CH2CO2R6, wherein Re is hydrogen (-H), Ci-Cg-alkyl, or Re is absent (e.g., Rx is -CH2CH2CO2'); R4 is hydrogen; and R5 is hydrogen.
The imidazoline can be a compound of formula (III), wherein R1 is unsubstituted C2-C6-alkyl; R2 is -C17H35, -C17H33, or -C17H31; R4 is hydrogen; and R5 is hydrogen.
The imidazoline can be a compound of formula (III), wherein R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31; R2 is C17H35, -C17H33, or -C17H3G R4 is hydrogen; and R5 is hydrogen.
The imidazoline can be a compound of formula (III), wherein R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R are each a -C2-alkyl-CO2R , wherein R is hydrogen or is absent (e.g., R is C2-alkyl-CO2’'); R2 is -C17H35, -C17H33, or -C17H31; R4 is hydrogen; and R5 is hydrogen.
It is to be understood, whether explicitly set forth or not, that formula (I), formula (II), and formula (III) are each intended to encompass the tautomeric, racemic, enantiomeric, diastereomeric, zwitterionic, and sait forms of said formulas. The imidazolines can exist in a zwitterionic form where R3 and/or Rx is derived from an acrylic acid.
The imidazoline compound can be présent in the compositions in an amount of 1 wt % to 50 wt %, 2 wt % to 40 wt %, 3 wt % to 30 wt %, 4 wt% to 20 wt %, 5 wt % to 17 wt %, 6 wt % to 16 wt %, 7 wt % to 15 wt %, 8 wt % to 14 wt %, 9 wt % to 13 wt %, or 10 wt % to 12 wt %, based on total weight of the composition. The imidazoline compound can constitute about 1 wt %, about 2 wt %, about 3 wt %, about 4 wt %, about 5 wt %, about 6 wt %, about 7 wt %, about 8 wt %, about 9 wt %, about 10 wt %, about 11 wt %, about 12 wt %, about 13 wt %, about 14 wt %, about 15 wt %, about 16 wt %, about 17 wt %, about 18 wt %, about 19 wt %, or about 20 wt % of the composition, based on total weight of the composition. The composition can comprise about 11 wt % of the imidazoline compound, based on total weight of the composition. The composition can comprise 11 wt % of the imidazoline compound, based on total weight of the composition.
b. Quatemary Amines
The compositions disclosed herein include a quatemary amine. Suitable quatemary amines include, but are not limited to, alkyl, hydroxyalkyl, alkylaryl, arylalkyl or arylamine quatemary salts.
Suitable alkyl, hydroxyalkyl, alkylaryl arylalkyl or arylamine quatemary salts include those alkylaryl, arylalkyl and arylamine quatemary salts of the formula [N+R5aR6aR7aR8a][X ] wherein R5a, R6a, R7a, and R8a contain one to 18 carbon atoms, and X is Cl, Br or I. For the quatemary amine, R5a, R6a, R7a, and R8a can each independently be selected from the group consisting of alkyl (e.g., Ci-Cjg alkyl), hydroxyalkyl (e.g., Ci-Cig hydroxyalkyl), and arylalkyl (e.g., benzyl). The mono or polycyclic aromatic amine sait with an alkyl or alkylaryl halide include salts of the formula [N+R5aR6aR7aR8a][XT] wherein R5a, R6a, R7a, and R8a contain one to 18 carbon atoms, and X is Cl, Br or I.
Suitable quatemary ammonium salts include, but are not limited to, tetramethyl ammonium chloride, tetraethyl ammonium chloride, tetrapropyl ammonium chloride, tetrabutyl ammonium chloride, tetrahexyl ammonium chloride, tetraoctyl ammonium chloride, benzyltrimethyl ammonium chloride, benzyltriethyl ammonium chloride, phenyltrimethyl ammonium chloride, phenyltriethyl ammonium chloride, cetyl benzyldimethyl ammonium chloride, hexadecyl trimethyl ammonium chloride, dimethyl alkyl benzyl quatemary ammonium compounds, monomethyl dialkyl benzyl quatemary ammonium compounds, trimethyl benzyl quatemary ammonium compounds, and trialkyl benzyl quatemary ammonium compounds, wherein the alkyl group can contain between about 1 and about 24 carbon atoms, about 10 and about 18 carbon atoms, or about 12 to about 16 carbon atoms, such as for example, C12-16 benzyl dimethyl ammonium chloride. Suitable quatemary ammonium compounds (quats) include, but are not limited to, trialkyl, dialkyl, dialkoxy alkyl, monoalkoxy, benzyl, and imidazolinium quatemary ammonium compounds, salts thereof, the like, and combinations thereof. The quatemary ammonium sait can be an alkylamine benzyl quatemary ammonium sait, a benzyl triethanolamine quatemary ammonium sait, or a benzyl dimethylaminoethanolamine quatemary ammonium sait.
The quatemary amine can be a benzalkonium sait represented by the formula:
x-
wherein n is 8, 10, 12, 14, 16, or 18; and X is Cl, Br or I.
The quatemary amine can be a mixture of benzalkonium salts wherein n is 8, 10,
12, 14, 16, and 18.
The quatemary amine can be a mixture of benzalkonium salts wherein n is 12, 14, 16, and 18.
The quatemary amine can be a mixture of benzalkonium salts wherein n is 12, 14, and 16.
The quatemary amine can be a mixture of benzalkonium salts wherein n is 12, 14, 16, and 18 and X is Cl.
The quatemary amine can be a mixture of benzalkonium salts wherein n is 12, 14, and 16, and X is Cl.
The quatemary amine can be an alkyl pyridinium quatemary sait such as those represented by the general formula:
R9aB wherein R9a is an alkyl group, an aryl group, or an arylalkyl group, wherein said alkyl groups hâve from 1 to about 18 carbon atoms and B is Cl, Br or I. Among these compounds are alkyl pyridinium salts and alkyl pyridinium benzyl quats. Exemplary compounds include methyl pyridinium chloride, ethyl pyridinium chloride, propyl pyridinium chloride, butyl pyridinium chloride, octyl pyridinium chloride, decyl pyridinium chloride, lauryl pyridinium chloride, cetyl pyridinium chloride, benzyl pyridinium and an alkyl benzyl pyridinium chloride, preferably wherein the alkyl is a Cj-Cô hydrocarbyl group.
The quatemary amine can be présent in the compositions in an amount of 0.1 wt % to 80 wt%, 1 wt % to 40 wt %, 5 wt % to 35 wt %, 10 wt % to 30 wt %, 15 wt % to 25 wt %, 16 wt % to 24 wt %, 17 wt % to 23 wt %, 18 wt % to 22 wt %, or 19 wt % to 21 wt %, based on total weight of the composition. The quatemary amine constitutes about 5 wt %, about 6 wt %, about 7 wt %, about 8 wt %, about 9 wt %, about 10 wt %, about 11 wt %, about 12 wt %, about 13 wt %, about 14 wt %, about 15 wt %, about 16 wt %, about 17 wt %, about 18 wt %, about 19 wt %, about 20 wt %, about 21 wt %, about 22 wt %, about 23 wt %, about 24 wt %, about 25 wt %, about 26 wt %, about 27 wt %, about 28 wt %, about 29 wt %, about 30 wt %, about 31 wt %, about 32 wt %, about 33 wt %, about 34 wt %, or about 35 wt % of the composition, based on total weight of the composition. The quatemary amine is présent in an amount of about 20 wt % or about 21 wt %, based on total weight of the composition. The quatemary amine is présent in an amount of 20.5 wt %, based on total weight of the composition.
The composition can include 5 wt % to 35 wt % of quatemary amine comprising Ci?-benzyl dimethyl ammonium chloride (e.g., 4 wt % to 20 wt %, based on total weight of the composition), C^-benzyl dimethyl ammonium chloride (e.g., 1 wt % to 10 wt %, based on total weight of the composition), Ci6-benzyl dimethyl ammonium chloride (e.g., 0.1 wt % to 5 wt%, based on total weight of the composition), and Cig-benzyl dimethyl ammonium chloride (e.g., 0.5 wt % or less, based on total weight of the composition). The composition can include about 20 wt % or about 21 wt % of quatemary amine comprising Cn-benzyl dimethyl ammonium chloride (e.g., 14.5 wt %, based on total weight of the composition), Cu-benzyl dimethyl ammonium chloride (e.g., 5 wt %, based on total weight of the composition), Ci6-benzyl dimethyl ammonium chloride (e.g., 1 wt%, based on total weight of the composition), and Cig-benzyl dimethyl ammonium chloride (e.g., 0.2 wt % or less, based on total weight of the composition).
c. Phosphonium Compounds
The compositions disclosed herein include at least one phosphonium compound, and in particular, a phosphonium sait. Suitable phosphonium salts include, but are not limited to, alkyltris(hydroxyorgano)phosphonium salts, alkenyltris(hydroxyorgano)phosphonium salts, and tetrakis(hydroxyorgano)phosphonium salts. The alkyltris(hydroxyorgano)phosphonium salts can be C1-C3alkyltris(hydroxymethyl)phosphonium salts. The alkenyltris(hydroxyorgano)phosphonium salts can be C2-C3alkenyltris(hydroxymethyl)phosphonium salts. The tetrakis(hydroxyorgano)phosphonium salts can be tetrakis(hydroxymethyl)phosphonium salts, including, but not limited to, tetrakis(hydroxymethyl)phosphonium sulphate (THPS), tetrakis(hydroxymethyl)phosphonium chloride, tetrakis(hydroxymethyl)phosphonium phosphate, tetrakis(hydroxymethyl)phosphonium formate, tetrakis(hydroxymethyl)phosphonium acetate, and tetrakis(hydroxymethyl)phosphonium oxalate. The phosphonium sait can be tetrakis(hydroxymethyl)phosphonium sulphate (THPS).
The phosphonium sait can be présent in the compositions in an amount of 0.1 wt % to 80 wt%, 0.5 wt % to 50 wt%, 1 wt % to 14 wt %, 2 wt % to 13 wt %, 3 wt % to 12 wt %, 4 wt % to 11 wt %, 5 wt % to 10 wt %, 6 wt % to 9 wt %, or 7 wt % to 8 wt %, based on total weight of the composition. The phosphonium sait constitutes about 1 wt %, about 2 wt %, about 3 wt %, about 4 wt %, about 5 wt %, about 6 wt %, about 7 wt %, about 8 wt %, about 9 wt %, about 10 wt %, about 11 wt %, about 12 wt %, about 13 wt %, or about 14 wt % of the composition, based on total weight of the compositionThe phosphonium sait can be présent in an amount of about 7 wt %, based on total weight of the composition. The phosphonium sait can be présent in an amount of 7.5 wt %, based on total weight of the composition.
d. Demulsifiers
The compositions disclosed herein can include a demulsifier (also referred to as an émulsion breaker). Suitable émulsion breakers include, but are not limited to, dodecylbenzylsulfonic acid (DDBSA), the sodium sait of xylenesulfonic acid (NAXSA), epoxylated and propoxylated compounds, anionic cationic and nonionic surfactants, and resins, such as polyoxyalkylenes, vinyl polymers, polyamines, polyamides, phenolics, and silicone polyethers. The émulsion breaker can be a vinyl polymer, such as: acrylic acid, polymer with t-butylphenol, formaldéhyde, maleic anhydride, propylene oxide, and ethylene oxide (CAS Registry Number: 178603-70-8).
The demulsifier can be présent in an amount of 0.1 wt % to 30 wt %, 0.5 wt % to 10 wt %, or 1 wt % to 5 wt %, based on total weight of the composition. The demulsifier constitutes about 1 wt %, about 2 wt %, about 3 wt %, about 4 wt %, or about 5 wt % of the composition, based on total weight of the composition. The compositions comprise about 2 wt % or about 3 wt % of the demulsifier, based on total weight of the composition. The composition comprises 2.6 wt % of the demulsifier, based on total weight of the composition.
e. Synergist
The compositions disclosed herein can include a synergistic component. Suitable synergist compounds include, but are not limited to, thioglycolic acid, 3,3'dithiodipropionic acid, thiosulfate, thiourea, 2-mercaptoethanol, L-cysteine, and tert-butyl mercaptan. The synergistic compound can be 2-mercaptoethanol.
The synergist can be présent in an amount of 0.01 wt % to 10 wt %, 0.1 wt % to 8 wt %, 0.5 wt % to 7 wt %, 1 wt % to 6 wt %, 2 wt % to 5 wt %, or 3 wt % to 4 wt %, based on total weight of the composition. The synergist can constitute about 0.5 wt %, about 1 wt %, about 1.5 wt %, about 2.0 wt %, about 2.5 wt %, about 3.0 wt %, about 3.5 wt %, about 4.0 wt %, about 4.5 wt %, about 5.0 wt %, about 5.5 wt %, or about 6.0 wt % of the composition, based on total weight of the composition. The composition can comprise about 3.5 wt % of the synergist, based on total weight of the composition. The composition can comprise 3.5 wt % of the synergist, based on total weight of the composition.
f. Solvents
The compositions disclosed herein can include a solvent. Suitable solvents include, but are not limited to, alcohols, hydrocarbons, ketones, ethers, aromatics, amides, nitriles, sulfoxides, esters, glycol ethers, aqueous Systems, and combinations thereof. The solvent can be water, isopropanol, methanol, éthanol, 2-ethylhexanol, heavy aromatic naphtha, toluene, ethylene glycol, ethylene glycol monobutyl ether (EGMBE), diethylene glycol monoethyl ether, or xylene. Représentative polar solvents suitable for formulation with the composition include water, brine, seawater, alcohols (including straight chain or branched aliphatic such as methanol, éthanol, propanol, isopropanol, butanol, 2-ethylhexanol, hexanol, octanol, decanol, 2-butoxyethanol, etc.), glycols and dérivatives (ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, ethylene glycol monobutyl ether, etc.), ketones (cyclohexanone, diisobutylketone), N-methylpyrrolidinone (NMP), N,Ndimethylformamide and the like. Représentative non-polar solvents suitable for formulation with the composition include aliphatics such as pentane, hexane, cyclohexane, methylcyclohexane, heptane, decane, dodecane, diesel, and the like; aromatics such as toluene, xylene, heavy aromatic naphtha, fatty acid dérivatives (acids, esters, amides), and the like.
The solvent can be methanol, isopropanol, 2-ethylhexanol, or a combination thereof. Further, the solvent can be methanol, isopropanol, 2-ethylhexanol, water, or a combination thereof.
A composition of the invention can comprise from 0 to 99 percent, 1 to 98 percent, 10 to 80 percent, 20 to 70 percent, 30 to 60 percent, or 40 to 55 percent by weight of one or more solvents, based on total weight of the composition.
A composition of the invention can comprise about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, or about 95% by weight of one or more solvents, based on total weight of the composition. A composition of the invention comprises about 40% of one or more alcoholic solvents and about 15% of water. A composition of the invention can comprise about 40% of a methanol/isopropanol mixture and about 15% of water. A composition of the invention can comprise 40% of a methanol/isopropanol mixture and 14.9% of water.
The compositions of the invention optionally include one or more additional additives. Suitable additives include, but are not limited to, corrosion inhibitors, asphaltene inhibitors, paraffm inhibitors, scale inhibitors, emulsifiers, water clarifiers, dispersants, hydrogen sulfide scavengers, gas hydrate inhibitors, biocides, pH modifiers, and surfactants.
g. Corrosion Inhibitors
Suitable corrosion inhibitors for inclusion in the compositions include, but are not limited to, mono-, di-or trialkyl or alkylaryl phosphate esters; phosphate esters of hydroxylamines; phosphate esters of polyols; and monomeric or oligomeric fatty acids.
Suitable mono-, di-and trialkyl as well as alkylaryl phosphate esters and phosphate esters of mono, di, and triethanolamine typically contain between from 1 to about 18 carbon atoms. Preferred mono-, di-and trialkyl phosphate esters, alkylaryl or arylalkyl phosphate esters are those prepared by reacting a C3-C18 aliphatic alcohol with phosphorous pentoxide. The phosphate intermediate interchanges its ester groups with triethyl phosphate with triethylphosphate producing a more broad distribution of alkyl phosphate esters. Altematively, the phosphate ester can be made by admixing with an alkyl diester, a mixture of low molecular weight alkyl alcohols or diols. The low molecular weight alkyl alcohols or diols preferably include Cô to Cio alcohols or diols. Further, phosphate esters of polyols and their salts containing one or more 2-hydroxyethyl groups, and hydroxylamine phosphate esters obtained by reacting polyphosphoric acid or phosphorus pentoxide with hydroxylamines such as diethanolamine or triethanolamine are preferred.
The corrosion inhibitor can be a monomeric or oligomeric fatty acid. Preferred are C14-C22 saturated and unsaturated fatty acids as well as dimer, trimer and oligomer products obtained by polymerizing one or more of such fatty acids.
h. Asphaltene Inhibitors
Suitable asphaltene inhibitors include, but are not limited to, aliphatic sulphonic acids; alkyl aryl sulphonic acids; aryl sulfonates; lignosulfonates; alkylphenol/aldehyde resins and similar sulfonated resins; polyolefin esters; polyolefm imides; polyolefin esters with alkyl, alkylenephenyl or alkylenepyridyl functional groups; polyolefin amides; polyolefin amides with alkyl, alkylenephenyl or alkylenepyridyl functional groups; polyolefin imides with alkyl, alkylenephenyl or alkylenepyridyl functional groups; alkenyl/vinyl pyrrolidone copolymers; graft polymers of polyolefins with maleic anhydride or vinyl imidazole; hyperbranched polyester amides; polyalkoxylated asphaltenes, amphoteric fatty acids, salts of alkyl succinates, sorbitan monooleate, and polyisobutylene succinic anhydride.
i. Paraffin Inhibitors
Suitable paraffin inhibitors include, but are not limited to, paraffin crystal modifiers, and dispersant/crystal modifier combinations. Suitable paraffin crystal modifiers include, but are not limited to, alkyl acrylate copolymers, alkyl acrylate vinylpyridine copolymers, ethylene vinyl acetate copolymers, maleic anhydride ester copolymers, branched polyethylenes, naphthalene, anthracene, microcrystalline wax and/or asphaltenes. Suitable dispersants include, but are not limited to, dodecyl benzene sulfonate, oxyalkylated alkylphenols, and oxyalkylated alkylpnenolic resins.
j. S cale Inhibitors
Suitable scale inhibitors include, but are not limited to, phosphates, phosphate esters, phosphoric acids, phosphonates, phosphonic acids, polyacrylamides, salts of acrylamido-methyl propane sulfonate/acrylic acid copolymer (AMPS/AA), phosphinated maleic copolymer (PHOS/MA), and salts of a polymaleic acid/acrylic acid/acrylamido-methyl propane sulfonate terpolymer (PMA/AMPS).
k. Emulsifiers
Suitable emulsifiers include, but are not limited to, salts of carboxylic acids, products of acylation reactions between carboxylic acids or carboxylic anhydrides and amines, and alkyl, acyl and amide dérivatives of saccharides (alkyl-saccharide emulsifiers).
l. Water Clarifiers
Suitable water clarifiers include, but are not limited to, inorganic métal salts such as alum, aluminum chloride, and aluminum chlorohydrate, or organic polymers such as acrylic acid based polymers, acrylamide based polymers, polymerized amines, alkanolamines, thiocarbamates, and cationic polymers such as diallyldimethylammonium chloride(DADMAC).
m. Dispersants
Suitable dispersants include, but are not limited to, aliphatic phosphonic acids with 2-50 carbons, such as hydroxyethyl diphosphonic acid, and aminoalkyl phosphonic acids, e.g. polyaminomethylene phosphonates with 2-10 N atoms e.g. each bearing at least one methylene phosphonic acid group; examples of the latter are ethylenediamine tetra(methylene phosphonate), diethylenetriamine penta(methylene phosphonate) and the triamine- and tetramine-polymethylene phosphonates with 2-4 methylene groups between each N atom, at least 2 of the numbers of methylene groups in each phosphonate being different. Other suitable dispersion agents include lignin or dérivatives of lignin such as lignosulfonate and naphthalene sulfonic acid and dérivatives.
n. Hydrogen Sulfide Scavengers
Suitable additional hydrogen sulfide scavengers include, but are not limited to, oxidants (e.g., inorganic peroxides such as sodium peroxide, or chlorine dioxide), aldéhydes (e.g., of 1-10 carbons such as formaldéhyde or glutaraldehyde or (meth)acrolein), triazines (e.g., monoethanol amine triazine, monomethylamine triazine, and triazines from multiple amines or mixtures thereof), and glyoxal.
o. Gas Hydrate Inhibitors
Suitable gas hydrate inhibitors include, but are not limited to, thermodynamic hydrate inhibitors (THI), kinetic hydrate inhibitors (KHI), and anti-agglomerates (AA). Suitable thermodynamic hydrate inhibitors include, but are not limited to, NaCl sait, KC1 sait, CaCl2 sait, MgCl2 sait, NaBr2 sait, formate brines (e.g. potassium formate), polyols (such as glucose, sucrose, fructose, maltose, lactose, gluconate, monoethylene glycol, diethylene glycol, triethylene glycol, monopropylene glycol, dipropylene glycol, tripropylene glycols, tetrapropylene glycol, monobutylene glycol, dibutylene glycol, tributylene glycol, glycerol, diglycerol, triglycerol, and sugar alcohols (e.g. sorbitol, mannitol)), methanol, propanol, éthanol, glycol ethers (such as diethyleneglycol monomethylether, ethyleneglycol monobutylether), and alkyl or cyclic esters of alcohols (such as ethyl lactate, butyl lactate, methylethyl benzoate). Suitable kinetic hydrate inhibitors and antiagglomerates include, but are not limited to, polymers and copolymers, polysaccharides (such as hydroxy-ethylcellulose (HEC), carboxymethylcellulose (CMC), starch, starch dérivatives, and xanthan), lactams (such as polyvinylcaprolactam, polyvinyl lactam), pyrrolidones (such as polyvinyl pyrrolidone of various molecular weights), surfactants (such as fatty acid salts, ethoxylated alcohols, propoxylated alcohols, sorbitan esters, ethoxylated sorbitan esters, polyglycerol esters of fatty acids, alkyl glucosides, alkyl polyglucosides, alkyl sulfates, alkyl sulfonates, alkyl ester sulfonates, alkyl aromatic sulfonates, alkyl betaine, alkyl amido betaines), hydrocarbon based dispersants (such as lignosulfonates, iminodisuccinates, polyaspartates), amino acids, and proteins.
p. Biocides
Suitable additional biocides include, but are not limited to, oxidizing and nonoxidizing biocides. Suitable non-oxidizing biocides include, for example, aldéhydes (e.g., formaldéhyde, glutaraldehyde, and acrolein), amine-type compounds (e.g., quatemary amine compounds and cocodiamine), halogenated compounds (e.g., bronopol and 2-2-dibromo-3-nitrilopropionamide (DBNPA)), sulfur compounds (e.g., isothiazolone, carbamates, and metronidazole), and quatemary phosphonium salts (e.g., tetrakis(hydroxymethyl)phosphonium sulfate (THPS)). Suitable oxidizing biocides include, for example, sodium hypochlorite, trichloroisocyanuric acids, dichloroisocyanuric acid, calcium hypochlorite, lithium hypochlorite, chlorinated hydantoins, stabilized sodium hypobromite, activated sodium bromide, brominated hydantoins, chlorine dioxide, ozone, and peroxides.
q. pH Modifiers
Suitable pH modifiers include, but are not limited to, alkali hydroxides, alkali carbonates, alkali bicarbonates, alkaline earth métal hydroxides, alkaline earth métal carbonates, alkaline earth métal bicarbonates and mixtures or combinations thereof. Exemplary pH modifiers include NaOH, KOH, Ca(OH)2, CaO, Na2CO3, KHCO3, K2CO3, NaHCO3, MgO, and Mg(OH)2.
r. Surfactants
Suitable surfactants include, but are not limited to, anionic surfactants, cationic surfactants, zwitterionic surfactants, and nonionic surfactants. Anionic surfactants include alkyl aryl sulfonates, olefm sulfonates, paraffin sulfonates, alcohol sulfates, alcohol ether sulfates, alkyl carboxylates and alkyl ether carboxylates, and alkyl and ethoxylated alkyl phosphate esters, and mono and dialkyl sulfosuccinates and sulfosuccinamates. Cationic surfactants include alkyl trimethyl quatemary ammonium salts, alkyl dimethyl benzyl quatemary ammonium salts, dialkyl dimethyl quatemary ammonium salts, and imidazolinium salts. Nonionic surfactants include alcohol alkoxylates, alkylphenol alkoxylates, block copolymers of ethylene, propylene and butylène oxides, alkyl dimethyl amine oxides, alkylbis(2-hydroxyethyl) amine oxides, alkyl amidopropyl dimethyl amine oxides, alkylamidopropyl-bis(2-hydroxyethyl) amine oxides, alkyl polyglucosides, polyalkoxylated glycerides, sorbitan esters and polyalkoxylated sorbitan esters, and alkoyl polyethylene glycol esters and diesters. Also included are betaines and sultanes, amphoteric surfactants such as alkyl amphoacetates and amphodiacetates, alkyl amphopropripionates and amphodipropionates, and alkyliminodiproprionate. The surfactant can be a quatemary ammonium compound, an amine oxide, an ionic or non-ionic surfactant, or any combination thereof. Suitable quatemary amine compounds include, but are not limited to, alkyl benzyl ammonium chloride, benzyl cocoalkyl(Cj2-Ci8)dimethylammonium chloride, dicocoalkyl (Ci2Ci8)dimethylammonium chloride, ditallow dimethylammonium chloride, di(hydrogenated tallow alkyl)dimethyl quatemary ammonium methyl chloride, methyl bis(2-hydroxyethyl cocoalkyl(Ci2-Ci8) quatemary ammonium chloride, dimethyl(2-ethyl) tallow ammonium methyl sulfate, ndodecylbenzyldimethylammonium chloride, n-octadecylbenzyldimethyl ammonium chloride, n-dodecyltrimethylammonium sulfate, soya alkyltrimethylammonium chloride, and hydrogenated tallow alkyl (2-ethylhyexyl) dimethyl quatemary ammonium methyl sulfate.
s. Additional Components
Compositions made according to the invention can further include additional functional agents or additives that provide a bénéficiai property. Additional agents or additives will vary according to the particular composition being manufactured and its intended use as one skilled in the art will appreciate.
Altematively, the compositions do not contain any of the additional agents or additives.
3. Synthesis
The compounds and compositions of the invention can be better understood in connection with the following synthetic schemes and methods which illustrate a means by which the compounds can be prepared.
Scheme 1
f nan-r1 M R4 R5 | Rb 0 + Ra^^ORe Rc | ---► R N^n-'r M R4 R5 |
(2) | (3) | (1) |
As shown in Scheme 1, compounds of formula (1) can be prepared by reacting an imidazoline of formula (2) with an acrylic acid of formula (3), wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, and Re are as defined above. The imidazoline of formula (2) can be prepared from reacting a diamine, such as ethylene diamine (EDA), diethylene triamine (DETA), or triethylene tetraamine (TETA) with a long chain fatty acid, such as tall oil fatty acid (TOFA). The compound of formula (3) introduced in the représentative reaction schemes generally include α,β-unsaturated carboxylic fatty acids and amide and ester dérivatives thereof; unsaturated sulfonic and phosphonic fatty acids; and their combinations. The compound of formula (3) can be selected from the group consisting of substituted and unsubstituted α,β-unsaturated carboxylic fatty acids and amide and ester dérivatives thereof, having from 3 to about 11 carbon atoms, or a sait thereof; substituted and unsubstituted α,βunsaturated fatty acids having from 2 to about 11 carbon atoms, or a sait thereof; and combinations thereof.
For Scheme 1, R4, R5, Ra, Rb, Rc, and Re are each hydrogen. Additionally, R1 is C2-Cio-alkyl, C2-C8-alkyl, or C2-C6-alkyl; and R4, R5, Ra, Rb, Rc, and Re are each hydrogen. Further, R1 is C2-Cio-alkyl, C2-C8-alkyl, or C2-Cg-alkyl; R2 is a C17 radical; and R4, R5, Ra, Rb, Rc, and Re are each hydrogen. Also, R1 is C2-Cio-alkyl, O
C2-C8-alkyl, or C2-Cô-alkyl; R is a radical derived from coconut oil, beef tallow, or tall oil fatty acids (TOFA); and R4, R5, Ra, Rb, Rc, and Re are each hydrogen.
Scheme 2 | ||
nAn^r1 )—( | Rb 0 + Ra^^OR6 Rc | Λ Δ 3 X /RX -----► R-mAmz . N^N-^r / \ |
R4 R5 | R4 R5 | |
(2) | (3) | (4) |
As shown in Scheme 2, compounds of formula (4) can be prepared by reacting an imidazoline of formula (2) with an acrylic acid of formula (3), wherein R1, R2, R3, Rx, R4, R5, Ra, Rb, Rc, and Re are as defined above.
For Scheme 2, R4, R5, Ra, Rb, Rc, and Re are each hydrogen. Additionally, R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or
-C17H3ij R2 is -Ci7H35, -Ci7H33, or -Ci7H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Cj-Cô-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2’); Rx is CH2CH2CO2Re, wherein Re is hydrogen (-H), Cj-Cg-alkyl, or Re is absent (e.g., Rx is -CH2CH2CO2'); R4 is hydrogen; and R5 is hydrogen. Further, R1 is linear C2alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen or is absent (e.g., R12 is -C2-alkyl-CO2'); R2 is -Ci7H35, -Ci7H33, or -Ci7H3i; R3 is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Ci-Cô-alkyl, or Re is absent (e.g., R3 is -CH2CH2CO2 ); Rx is -CH2CH2CO2Re, wherein Re is hydrogen (-H), Ci-Cg-alkyl, or Re is absent (e.g., Rx is -CH2CH2CO2‘); R4 is hydrogen; and R5 is hydrogen.
Imidazolines for use with compositions of the invention can also be commercially available.
The compounds can be further modified, for example, by manipulation of substituents. These manipulations can include, but are not limited to, réduction, oxidation, organometallic cross-coupling, alkylation, acylation, and hydrolysis reactions which are commonly known to those skilled in the art. In some cases, the order of carrying out the foregoing reaction schemes can be varied to facilitate the reaction or to avoid unwanted reaction products.
4. Methods of Use
The compositions of the invention can be used in any industry where it is désirable to control biofouling and/or inhibit corrosion at a surface. The compositions can preferably be used as biocides for use in oil and gas applications. By treating a gas or liquid stream with an effective amount of a composition of the invention, the compositions can provide significant planktonic kill and enhanced biofilm control by delaying regrowth kinetics of the biofilms.
The compositions can be used in water Systems, condensate/oil systems/gas Systems, or any combination thereof.
The compositions can be applied to a gas or liquid produced or used in the production, transportation, storage, and/or séparation of crude oil or natural gas. The compositions can be applied to a gas stream used or produced in a coal-fired process, such as a coal-fired power plant.
The compositions can be applied to a gas or liquid produced or used in a wastewater process, a farm, a slaughter house, a land-fill, a municipality waste-water plant, a coking coal process, or a biofuel process.
A fluid to which the compositions can be introduced can be an aqueous medium. The aqueous medium can comprise water, gas, and optionally liquid hydrocarbon. A fluid to which the compositions can be introduced can be a liquid hydrocarbon. The liquid hydrocarbon can be any type of liquid hydrocarbon including, but not limited to, crude oil, heavy oil, processed residual oil, bitminous oil, coker oils, coker gas oils, fluid catalytic cracker feeds, gas oil, naphtha, fluid catalytic cracking slurry, diesel fuel, fuel oil, jet fuel, gasoline, and kerosene. The fluid or gas can be a refined hydrocarbon product.
A fluid or gas treated with a composition of the invention can be at any selected température, such as ambient température or an elevated température. The fluid (e.g., liquid hydrocarbon) or gas can be at a température of from about 40 °C to about 250 °C. The fluid or gas can be at a température of from -50 °C to 300 °C, 0 °C to 200 °C, 10 °C to 100 °C, or 20 °C to 90 °C.
The compositions of the invention can be added to a fluid at various levels of water eut. For example, the water eut can be from 0% to 100% volume/volume (v/v), from 1% to 80% v/v, or from 1% to 60% v/v. The fluid can be an aqueous medium that contains various levels of salinity. The fluid can hâve a salinity of 0% to 25%, about 1% to 24%, or about 10% to 25% weight/weight (w/w) total dissolved solids (TDS).
The fluid or gas in which the compositions of the invention are introduced can be contained in and/or exposed to many different types of apparatuses. For example, the fluid or gas can be contained in an apparatus that transports fluid or gas from one point to another, such as an oil and/or gas pipeline. The apparatus can be part of an oil and/or gas refmery, such as a pipeline, a séparation vessel, a déhydration unit, or a gas line. The fluid can be contained in and/or exposed to an apparatus used in oil extraction and/or production, such as a wellhead. The apparatus can be part of a coal-fired power plant. The apparatus can be a scrubber (e.g., a wet flue gas desulfurizer, a spray dry absorber, a dry sorbent injector, a spray tower, a contact or bubble tower, or the like). The apparatus can be a cargo vessel, a storage vessel, a holding tank, or a pipeline connecting the tanks, vessels, or processing units. The fluid or gas can be contained in water Systems, condensate/oil systems/gas Systems, or any combination thereof.
The compositions of the invention can be introduced into a fluid or gas by any appropriate method for ensuring dispersai through the fluid or gas. The inhibitor composition is added at a point in a flow line upstream from the point at which corrosion prévention is desired. The compositions can be injected using mechanical equipment such as chemical injection pumps, piping tees, injection fittings, atomizers, quills, and the like. The compositions of the invention can be introduced with or without one or more additional polar or non-polar solvents depending upon the application and requirements. The compositions of the invention can be pumped into an oil and/or gas pipeline using an umbilical line. Capillary injection Systems can be used to deliver the compositions to a selected fluid. The compositions can be introduced into a liquid and mixed. The compositions can be injected into a gas stream as an aqueous or nonaqueous solution, mixture, or slurry. The fluid or gas can be passed through an absorption tower comprising a compound or composition of the invention.
The compositions can be applied to a fluid or gas to provide any selected concentration. In practice, the compositions of the invention are typically added to a flow line to provide an effective treating dose of the described compositions from about 0.01 to about 10,000 ppm. The compositions can be applied to a fluid or gas to provide a total actives (e.g., imidazoline, quatemary amine, phosphonium sait, demulsifier, and synergist) concentration of about 1 parts per million (ppm) to about 1,000,000 ppm, about 1 ppm to about 100,000 ppm, about 10 ppm to about 75,000 ppm, about 10 ppm to about 10,000 ppm, about 50 ppm to about 10,000 ppm, or about 100 ppm to about 500 ppm. The compositions can be applied to a fluid to provide an actives concentration of about 10 ppm to about 10,000 ppm, about 10 ppm to about 500 ppm, about 50 ppm to about 500 ppm, or about 100 ppm to about 500 ppm. The compositions are applied to a fluid or gas to provide an actives concentration of about 50 ppm, about 100 ppm, about 150 ppm, about
200 ppm, about 250 ppm, about 300 ppm, about 350 ppm, about 400 ppm, about
450 ppm, about 500 ppm, about 550 ppm, about 600 ppm, about 650 ppm, about
700 ppm, about 750 ppm, about 800 ppm, about 850 ppm, about 900 ppm, about
950 ppm, or about 1,000 ppm. Each system can hâve its own dose level requirements, and the effective dose level of a composition to sufficiently reduce the rate of corrosion can vary with the System in which it is used.
The compositions can be applied continuously, in batch, or a combination thereof. The composition doses can be continuous.
The composition doses can be intermittent (i.e., batch treatment).
The composition doses can be continuous/maintained and/or intermittent.
Dosage rates for continuous treatments typically range from about 10 to about 500 ppm, or about 10 to about 200 ppm.
Dosage rates for batch treatments typically range from about 10 to about 10,000 ppm.
The composition can be applied as a pill to a pipeline, providing a high dose (e.g., 10,000 ppm) of the composition.
The flow rate of a flow line in which the composition is used can be between 0 and 100 feet per second, or between 0.1 and 50 feet per second. In some cases, the compositions can be formulated with water in order to facilitate addition to the flow line.
The compositions can provide 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, or 100% planktonic kill. The compositions can provide 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, or 100% planktonic kill in a dynamic flow loop test after a 4-hour contact period with the biocide composition.
The dynamic flow loop can be characterized by a test System that holds approximately a selected volume of fluid (e.g., 1.5 liters) that are continually circulated over 1018 carbon steel biostuds (e.g., located in the 6 o’clock position of a modified Robbin’s device). The test fluid can be pumped through the System at a selected rate (e.g., approximately 3.1 gallons per minute), which allows for déposition of microorganisms and solids onto the biostuds. The health of the microbial population can be monitored (e.g., weekly) during the biofilm growth period (e.g., 7 weeks) using ATP quantification. After concluding the establishment of a mature biofilm, a biocide efficacy study can be initiated.
During the study, solid and fluid samples can be collected before and after the biocide treatment at scheduled intervals (e.g., 4 hours, 24 hours, 72 hours, or 120 hours). A baseline reading (e.g., solid and fluid samples) can be taken prior to the addition of the biocide to the individual flow loop. To study how quickly a biofilm is able to regrow after batch biocide treatment, the total biocide-treated fluid in each flow loop can be removed from the system and untreated production fluid added back into the system. Additional solid samples (e.g., biostuds) can be removed at selected time intervals (e.g., 24, 48 and either 72 or 120-hours) after the new fluid was added, so as to détermine how quickly the biofilm was able to regrow to its pretreatment size.
The compounds, compositions, methods, and processes of the invention will be better understood by reference to the following examples, which are intended as an illustration of and not a limitation upon the scope of the invention.
5. Examples
The foregoing can be better understood by reference to the following examples, which are presented for purposes of illustration and are not intended to limit the scope of the invention.
Imidazolines can be prepared as described in Examples 1-5, and as described in U.S. Patent Nos. 6,488,868, 7,057,050, and 7,951,754, the contents of which are hereby incorporated by reference in their entirety. Imidazolines can also be commercially available.
Example 1
To préparé the imidazoline above wherein R is -C17H35, -C17H33, or -CnHsi, sixty grams of Tall Oil Fatty Acid (TOFA) was placed in a 250 ml, 4-neck flask equipped with an overhead stirrer, thermocouple, addition tunnel and a Dean-Stark trap. The TOFA was heated to 60 °C and then 25 grams of N-propylethylenediamine was added dropwise rapidly. The resulting mixture tumed from light yellow to dark red and exothermed to 100 °C. The mixture was then heated to 120-140 °C for 3 hours. The hydrocarbon collected in the trap was retumed to the flask. The mixture was thereafter heated to 160 °C for 1 hour while allowing water to collect in the Dean-Stark trap.
The resulting mixture was then heated at 165 °C for 2 hours and then at 225 °C for an additional hour during which time any further evolved water was collected. A nitrogen sweep was applied and the speed of the overhead stirrer was increased to facilitate removal of water. Foliowing further heating of the mixture to 225 °C for an additional 1.5 hours, the reaction mixture was cooled and 65.9 grams of the resulting imidazoline mixture was then reacted with 18.7 grams of acrylic acid which was carefully added dropwise to the imidazoline product. A température rise of about 70-89 °C was observed. After exotherm had ceased, the reaction température was raised to about 100 °C for 2 hours. The resulting N-propyl-2heptadecenyl imidazoline acrylate was recovered.
Example 2
To préparé the imidazoline above wherein R2 is -CnH35, -C17H33 or -CnE^i, sixty grams of Tall Oil Fatty Acid (TOFA) was placed in a 250 ml, 4-neck flask equipped with an overhead stirrer, thermocouple, addition tunnel and a Dean-Stark trap. The TOFA was heated to 60 °C and then 28.5 grams (0.245 mol) of Nbutylethylenediamine was added dropwise rapidly. The resulting mixture tumed from light yellow to dark red and exothermed to 84 °C. The mixture was then heated to 160 °C for 3.5 hours until no further water evolved. The hydrocarbon collected in the trap was retumed to the flask. The mixture was thereafter heated to 160 °C for 1 hour while allowing water to collect in the Dean-Stark trap.
Fifty grams (0.132 mole) of the resulting mixture was then heated at 225 °C for an additional hour during which time any further evolved water was collected. A nitrogen sweep was applied and the speed of the overhead stirrer was increased to facilitate removal of water. Following further heating of the mixture to 225 °C for an additional 1.5 hours, the reaction mixture was cooled and 45.25 grams of the resulting imidazoline mixture was then reacted with 10.4 grams of acrylic acid which was carefully added dropwise to the imidazoline product. A température rise to about 88 °C was observed. After exotherm had ceased, the reaction température was raised to about 120 °C for 2 hours. The resulting N-butyl-2heptadecenyl imidazoline acrylate was recovered.
Example 3
To préparé the imidazoline above wherein R is -C17H35, -C17H33 or -C17H31, sixty grams of Tall Oil Fatty Acid (TOFA) was placed in a 250 ml, 4-neck flask equipped with an overhead stirrer, thermocouple, addition tunnel and a Dean-Stark trap. The TOFA was heated to 60 °C and 35.3 grams (0.265 mol) of Nhexylethylenediamine was added dropwise rapidly. The resulting mixture tumed from light yellow to dark red and exothermed to 87 °C. The mixture was heated to 160 °C for 3.5 hours until no further water evolved. The hydrocarbon collected in the trap was retumed to the flask. The mixture was thereafler heated at 160 °C for 1 hour while allowing water to collect in the Dean-Stark trap.
Sixty one grams of the resulting mixture was then heated at 225-230 °C for an hour and then at 225 °C for an additional hour during which time any further evolved water was collected. A nitrogen sweep was applied and the speed of the overhead stirrer was increased to facilitate removal of water. Following further heating of the mixture to 225 °C for an additional 1.5 hours, the reaction mixture was cooled and 55.93 grams of the resulting imidazoline mixture was then reacted in a 3-neck 250 ml flask with 18.7 grams of acrylic acid which was carefully added dropwise to the imidazoline product. A température rise to about 92 °C was observed. After exotherm had ceased, the reaction température was raised to about 120 °C for 2 hours. The resulting N-hexyl-2-heptadecenyl imidazoline acrylate was recovered.
Example 4
NH
O'
To préparé the imidazoline compound above wherein R2 and R14 are independently -C17H35, -C17H33 or -C17H31, 220.4 grams (0.78 moles) of a tall oil fatty acid mixture (TOFA-comprised of about 46% oleic acid, about 41% linoleic acid, about 4% stearic acid, and about 9% other acids) was weighed and placed into a 500 ml round bottom, four-neck flask equipped with an overhead stirrer, thermocouple, addition funnel, and Dean-Stark trap. The TOFA was heated to about 70 °C and 38.8 grams (0.38 moles) of diethylenetriamine was added dropwise, with stirring. An exotherm of about 35 °C was observed. The mixture was further heated at 130 °C for 1 hour and at 160 °C for 2 hours. The mixture was then held at 250 °C for 2 hours with a nitrogen gas sweep. 17.6 ml (about 86% theoretical amount of water for 100% imidazoline formation) of water was collected. The mixture was cooled and 60.8 grams (0.84 moles) of glacial acrylic acid was added dropwise, with stirring, which had an exotherm between 47 and 67 °C. This final mixture was heated at 120 to 125 °C for 2 hours to ensure complété reaction.
Example 5
CO2H
To préparé the imidazoline above wherein R is -C17H35, -C17H33 or -C17H31, 175 g (0.62 mol) of TOFA was placed in a 500 mL round bottom four-neck flask equipped with an overhead stirrer, addition funnel, thermocouple and Dean-Stark trap. The acid was heated to 60 °C and a sweep of nitrogen gas was maintained over the surface of the liquid throughout the reaction. When the température reached 60 °C, 82 g (0.8 mol) of DETA was added dropwise rapidly. An exotherm of about 40 °C was observed. The mixture was heated to 175 °C with stirring until the theoretical amount of water for amide formation (11g) was collected. The infrared spectrum of the mixture at this point indicated the presence of amide (absorption at about 1630 and 1550 cm'1) and ffee N-H (absorption at about 3315 cm'1). The température was increased to 225 °C and maintained there for 2 hours (84% of the theoretical amount of water for 100% imidazoline formation was collected). The infrared spectrum exhibited the same two broad bands noted above and a sharper, intense band between them around 1610 cm’1, indicative of imidazoline.
69.8 g (0.2 mol, presuming the composite molecular weight of the amine imidazoline is 349 g/mole) of the résultant amine imidazoline mixture was weighed into a 250 mL round bottom four-neck flask equipped with an overhead stirrer, addition tunnel and thermocouple. To this was added 43.2 g (0.6 mol) acrylic acid via the addition funnel. The exotherm was noted and the mixture heated at 120 °C for 2 hours.
Biocide Testing
Evaluation of the biocide compositions disclosed herein was performed through a dynamic flow loop test where both planktonic and sessile organisms could be monitored. To start this testing, fluid from the field, as well as cultured organisms from the field, were placed into the System and allowed to grow for approximately 7 weeks, providing a mature biofilm that can then be challenged by the biocide treatment.
The test System holds approximately 1.5 liters of fluid that are continually circulated over 1018 carbon steel biostuds located in the 6 o’clock position of a modified Robbin’s device. The device holds a maximum of eight biostuds in the 6 o’clock position. The production fluid was pumped through the System at a rate of approximately 3.1 gallons per minute, which allows for déposition of microorganisms and solids onto the biostuds. The health of the microbial population was monitored weekly during the biofilm growth period using ATP quantification.
After concluding the establishment of a mature biofilm, the sessile kill study was initiated. During the study, solid and fluid samples were collected before and after the biocide treatment at scheduled intervals. The following chemicals were tested in the System: (study 1) THPS was tested against THPS/quat #2, (study 2) THPS/quat #1, and (study 3) THPS/quat/imidazoline. A baseline reading was taken, during ail of the studies, prior to the addition of the chemical to the individual flow loop. This consisted of a fluid sample as well as two biostuds. After removal of the baseline sample, either (study 1) THPS or THPS/quat #2, (study 2) THPS/quat #1, (study 3) THPS/quat/imidazoline was added to a flow loop at the prédéterminé concentration with a 4 hour contact time. After the 4 hour treatment, a second fluid sample and two coupons were removed from each flow loop. The total fluid in each flow loop was then removed from the System and untreated production fluid added back to mimic a batch biocide treatment followed by continued production. Additional biostuds were removed at 24, 48 and either 72 or 120-hours after the new fluid was added to détermine how quickly the biofilm was able to regrow to its pretreatment size.
One of the features of this chemistry is the enhanced biofilm kill that a formulation has when the imidazoline is présent even though the imidazoline itself has no enhanced kill on planktonic organisms. Figure 1 shows a planktonic biocide efficacy kill study where varying amounts of imidazoline were mixed with a biocidal quatemary. As the amount of the imidazoline was increased, the microbial kill decreased, as shows in Figure 1.
Figure 2 is a compilation of three separate experiments illustrating the ability to kill microbes présent in a biofilm by using THPS alone, THPS in combination with one of two difcferent quats, or THPS with a quat plus the acrylated imidazoline. The initial data point before treatment is set to 100% and ail other readings are reported as a percent change compared to the baseline. THPS alone provides initial biofilm kill, but the biofilm is larger than it was before treatment within 24 hours. THPS plus the quats provided enhanced control with quat #2 compared to THPS alone but no enhanced control with quat #1. Quat #2 was Ν,Ν-dimethyl, Nalkyl-benzylammonium chloride wherein the alkyl was a mixture of C12, C14, and Ci6 alkyl groups. The imidazoline used was available commercially under the tradename Clean N Cor from Nalco. The THPS/quat/imidazoline provided a synergistic effect where biofilm growth was reduced to less than 0.3% of the initial size and maintained for at least 120 hours when the testing was stopped.
Planktonic kill in the dynamic flow loops was also evaluated immediately after a 4 hour contact time with the biocide. The results of that testing are shown in Table 1. Compared to THPS alone, the addition of a quat does provide some enhanced kill. The addition of a quat plus the imidazoline to THPS provided a synergistic effect where the planktonic kill was significantly enhanced compared to THPS or THPS plus quat only.
Table 1
Planktonic kill data | ||
Biocide | Dosage | % réduction |
THPS | 112.5 ppm active THPS | 81.8% |
THPS/quat #1 | 140 ppm active THPS | 94.4% |
THPS/quat#2 | 52.5 ppm active THPS | 83.2% |
THPS/quat#2 | 140 ppm active THPS | 91.0% |
THP S/quat/imidazoline | 47.5 ppm active THPS | 99.8% |
quat #1 = benzyl-(Ci2-Ci6 linear alkyl)-dimethyl-ammonium chloride quat #2 = same quat from the THPS/quat/imidazoline blend (without the imidazole)
Based on these results, a planktonic kill study, as described above, and a static sessile kill study were employed to détermine the ratio of the THPS/quat/imidazoline that yields the most synergistic effect. The results indicated that the formulations titled N-HF #2 and N-HF#3 provided the best overall kill for both the planktonic and static sessile tests, as shown in Figure 3. NHF#2 contained 45 wt.% Clean N Cor and N-HF#3 contained 40 wt.% Clean N Cor.c
Additional formulations were prepared with an émulsion breaker to enhance oil/water séparation when using the synergistic biocide formulations. For this test, synthetic brine and crude from the field were added to a 250 mL flask. Afiter the addition of the designated chemistry, the flask was mixed for 30 seconds at 2000 rpm. Once the mixing was completed, the height of each layer was recorded after 5, 20, and 60 minutes.
Figure 4 shows the blank, or négative control, against the synergistic biocide formulation without the émulsion breaker and the synergistic biocide formulation with the émulsion breaker at concentrations of 100 ppm, 500 ppm, and 1000 ppm, after 20 minutes. Observations revealed the crude émulsion seems to be tighter with the formulation including the émulsion breaker than formulation without the émulsion breaker. This provides an additional benefit to the biocide formulations.
After determining the ratio that yields the most synergistic effects and the addition of the émulsion breaker, an exemplary biocide formulation according to Table 2 was prepared. A sessile kill study was conducted to détermine the efficacy of the formulation of Table 2. This test revealed a 98.6% réduction in the planktonic community and a 95.2% réduction in the sessile community after a 4 hour contact time.
Table 2
Component | (wt%) | |
Imidazoline | imidazoline(s) of formula (I): r3N<î>N^r1 M R4 R5 (I) wherein R is substituted alkyl; R is C17H35, -C17H33, or -C17H31; R3 is CH2CH2CO2·; R4 is H; and R5 is H | 11 |
Quatemary Amine | benzalkonium salts of the formula: θΓ^ΝχΟηΗ2η+1 wherein nis 12, 14, 16, and/or 18; and Xis Cl | 20.5 |
Phosphonium Sait | tetrakis(hydroxymethyl)phosphonium sulphate (THPS): HO-'X+Z'-OH 0 ZO HO^Z \ X / -0 OH HO | 7.5 |
Demulsifier | acrylic acid, polymer with tbutylphenol, formaldéhyde, maleic anhydride, propylene oxide, and ethylene oxide (CAS Registry Number: 178603-70-8) | 2.6 |
Synergist | 2-mercaptoethanol | 3.5 |
Alcoholic Solvent | methanol/isopropanol | 40 |
Aqueous Solvent | Water | 14.9 |
Example 6:
A study was conducted to assess the corrosiveness of the biocide and two other commonly used biocide products. In this évaluation the corrosion rates of Cl018 carbon steel in CO2 saturated brine at 100% water eut were monitored in the presence of various biocides at concentrations of up to 5,000 ppm using the wheel box corrosion test at 80°C. The results for the three biocide types, V08, 75% THPS, and 50% glutaraldehyde, are provided in Figure 5 (A-C). Ail samples were run in triplicate. The blank or baseline corrosion rate in the 24 hour wheel box test provided an average corrosion rate of 58.60 mpy (mils pénétration per year) while the 75% THPS and 50% glutaraldehyde biocides resulted in corrosion rates of 53.78 and 30.07 mpy, respectively. Similar trends emerged for THPS and glutaraldehyde as the concentration of each increased. However, V08 yielded a corrosion rate of 5.14 mpy at 100 ppm. The data indicated that the concentration of V08 is inversely proportional to the corrosion rate. The V08 product included water, 2-ethylhexanol, iso-propyl alcohol, CleanN Cor from Nalco, THPS, and acrylic acid, polymer with t-butylphenol, formaldéhyde, maleic anhydride, propylene oxide, and ethylene oxide (CAS Registry Number: 178603-70-8). Overall the data revealed that V08 can provide corrosion protection.
Any ranges given either in absolute terms or in approximate terms are intended to encompass both, and any définitions used herein are intended to be clarifying and not limiting. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the spécifie examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard déviation found in their respective testing measurements. Moreover, ail ranges disclosed herein are to be understood to encompass any and ail subranges (including ail fractional and whole values) subsumed therein.
Furthermore, the invention encompasses any and ail possible combinations of some or ail of the various embodiments described herein. Any and ail patents, patent applications, scientific papers, and other references cited in this application, as well as any references cited therein, are hereby incorporated by reference in their entirety.
Claims (10)
- CLAIMS:1. A biocide composition an imidazoline compound;a quatemary amine; and a phosphonium compound;wherein the imidazoline compound has formula (I), (II), or (III),
R2 R2 R2 r3-n^n-r1 „ X x R^N^N^R1 nÀn^r1 )—( m M R4 R5 R4 R5 R4 R5 (l) (H) (III) whereinR1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);R2 is a radical derived from a fatty acid;R3 and Rx are independently selected from a radical derived from an unsaturated acid;R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; and R14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl. - 2. The composition of claim 1, wherein the imidazoline compound has formula (I), ïr3N^Nr1R4^ ^R5 (I) whereinR1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR6, -CO2R7, -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);R2 is a radical derived from a fatty acid;R3 * is selected from a radical derived from an unsaturated acid;R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; andR14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
- 3. The composition of claim 2, wherein (i) R1 is unsubstituted C2-Cô-alkyl; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Cj-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen, or (ii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H3i; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen, or (iii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen or R17 is absent; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Ce-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
- 4. The composition of claim 1, wherein the imidazoline compound has formula (II), □ X ZR R~N<?N-.R1R4 R5 (II) whereinR1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);R2 is a radical derived from a fatty acid;R3 and Rx are each independently selected from a radical derived from an unsaturated acid;R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; andR14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
- 5. The composition of claim 4, wherein (i) R1 is unsubstituted C2-C6-alkyl; R2 is -C17H35, -C17H33, or -C17H31; R3 is-CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; Rx is CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; R4 is hydrogen; andR5 is hydrogen, or (ii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal-N(R12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, -C17H33, or -C17H31; R2 is -C17H35, -C17H33, or -C17H31; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-C6-alkyl, or Re is absent; Rx is -CH2CH2CO2Re, wherein Re is hydrogen, CiCô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen, or (iii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen or R17 is absent; R2 is -Ci7H35, -C17H33, or -CnH3i; R3 is -CH2CH2CO2Re, wherein Re is hydrogen, Ci-Cô-alkyl, or Re is absent; Rx is -CH2CH2CO2Re, wherein Re is hydrogen, CiCô-alkyl, or Re is absent; R4 is hydrogen; and R5 is hydrogen.
- 6. The composition of claim 1, wherein the imidazoline compound has formula (III), (III) whereinR1, R4, and R5 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle, said alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle each independently, at each occurrence, unsubstituted or substituted with 1 to 3 substituents independently selected from halogen, -COR , -CO2R , -SO3R8, -PO3H2, -CON(R9)(R10), -OR11, and -N(R12)(R13);R2 is a radical derived from a fatty acid;R6, R7, R8, R9, R10, and R11 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl;R12 and R13 are each independently, at each occurrence, selected from hydrogen, alkyl, -COR14, -CO2R15, -alkyl-COR16, and -alkyl-CO2R17; andR14, R15, R16, and R17 are each independently, at each occurrence, selected from hydrogen, alkyl, and alkenyl.
- 7. The composition of claim 6, wherein (i) R1 is unsubstituted C2-C6-alkyl; R2 is -Ci7H35, -Ci7H33, or -Ci7H3i; R4 is hydrogen; and R5 is hydrogen, or (ii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R10 * 12)(R13), wherein R12 is hydrogen and R13 is -COR14, wherein R14 is -C17H35, C17H33, or -C17H31; R2 is -C17H35, -C17H33, or -C17H31; R4 is hydrogen; and R5 is hydrogen, or (iii) R1 is linear C2-alkyl, substituted with one substituent that is a terminal -N(R12)(R13), wherein R12 and R13 are each a -C2-alkyl-CO2R17, wherein R17 is hydrogen or R17 is absent; R2 is -C17H35, -C17H33, or -C17H31; R4 is hydrogen; and R5 is hydrogen..
- 8. The composition of claim 1, wherein the quatemary amine is selected from the group consisting of tetramethyl ammonium chloride, tetraethyl ammonium chloride, tetrapropyl ammonium chloride, tetrabutyl ammonium chloride, tetrahexyl ammonium chloride, tetraoctyl ammonium chloride, benzyltrimethyl ammonium chloride, benzyltriethyl ammonium chloride, phenyltrimethyl ammonium chloride, phenyltriethyl ammonium chloride, cetyl benzyldimethyl ammonium chloride, hexadecyl trimethyl ammonium chloride, dimethyl Ci2-j6alkyl benzyl ammonium chloride, monomethyl di-Ci2-i6-alkyl benzyl quatemary ammonium chloride, benzyl triethanolamine quatemary ammonium chloride, benzyl dimethylaminoethanolamine quatemary ammonium chloride, cocoalkyl dimethyl benzyl ammonium chloride, and combinations thereof.
- 9. The composition of claim 1, wherein the phosphonium compound is selected from the group consisting of tetrakis(hydroxymethyl)phosphonium sulphate (THPS), tetrakis(hydroxymethyl)phosphonium chloride, tetrakis(hydroxymethyl)phosphonium phosphate, tetrakis(hydroxymethyl)phosphonium formate, tetrakis(hydroxymethyl)phosphonium acetate, tetrakis(hydroxymethyl)phosphonium oxalate, and combinations thereof.
- 10. A method of controlling microbe prolifération in a System used in the production, transportation, storage, and séparation of crude oil and naturel gas, the method comprising contacting the System with an effective amount of a composition of claim 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61/861803 | 2013-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA17665A true OA17665A (en) | 2017-06-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9833002B2 (en) | Biocide compositions | |
AU2014296417B2 (en) | Organic disulfide based corrosion inhibitors | |
US11021383B2 (en) | Use of di-ionic compounds as corrosion inhibitors in a water system | |
JP7418211B2 (en) | Quaternary cationic polymer | |
CA2917104C (en) | Polyamine sulfonic acid salt functionning as an oilfield cleaner and corrosion inhibitor | |
EP3491106B1 (en) | Antifouling and hydrogen sulfide scavenging compositions | |
WO2014105764A1 (en) | Beta-amino ester gas hydrate inhibitors | |
JP7026672B2 (en) | Benzotriazole and triltriazole derivatives for corrosion reduction | |
OA17665A (en) | Biocide compositions | |
EP3662034B1 (en) | Thiol adducts for corrosion inhibition |